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The experiments which are required to directly assess the operational stability of 
thermostable biocatalysts can be time-consuming, troublesome, and, in the context of 
industry, expensive.  In the present work, we develop and validate two methods for 
quickly estimating the total turnover number (a useful indicator of lifetime productivity) 
of a biocatalyst for any desired operating temperature.  The first method is a heuristic 
approach, built upon a complete mathematical derivation from first principles, in which 
the total turnover number can be calculated from two simple biochemical measurements.  
The second method relies on a single non-isothermal, continuous-mode experiment in 
conjunction with mathematical modeling to determine the intrinsic deactivation 
parameters of the biocatalyst.  Both methods provide estimates of the total turnover 
number which are well within one order of magnitude of the values measured directly via 
isothermal aging tests and therefore are extremely valuable tools in terms of the amount 










 Biocatalysts are powerful tools.  A wide variety of commercially pertinent 
chemicals including pharmaceutical intermediates and specialty chemicals can be 
produced more quickly and efficiently, with fewer process steps to an extremely pure 
product, and with less environmental impact, when enzymes are used as catalysts.  
Enzymes are highly complex and specific molecules, either found in nature or borrowed 
as a template from nature, which typically offer better substrate specificity and 
enantioselectivity than almost any corresponding organic synthesis approach.  Recent 
developments such as high throughput screening and directed evolution have made it 
easier to identify enzymes which have activity toward a substrate of interest, and then to 
fine-tune their specificity. 
 For all of the advantages that biocatalysts can offer, they are still only used in a 
relatively modest number of large-scale applications.  One of the dominant limiting 
factors against their widespread application is concern about their operational stability.1 
Enzymes have evolved over time to function most effectively in conditions resembling 
physiological systems (which is part of their appeal from an environmental standpoint).  
However, the high concentrations of solvents, extreme pH, and elevated temperatures that 
are often used to improve the efficiency of a chemical process can have deleterious 
effects on an enzyme’s ability to properly catalyze the desired reaction.  Therefore, 
efforts toward understanding and improving enzyme stability are of utmost importance. 
1 
 A review of the theory and methodology relevant to the study of biocatalyst 
operational stability is presented in Chapter 2.  Especially important is the discussion of 
both the kinetic and thermodynamic stability of enzymes, since previous attempts to 
quantify the concept of enzyme thermostability all too often focus only on one of these 
two concepts.  Classical models of protein stability, as well as more recent improved 
models, are examined in the context of bioprocess productivity and some strategies for 
measuring the parameters pertinent to these models are discussed.  Details of the test case 
enzyme, TEM-1 β-lactamase, and the enzyme membrane reactor (EMR) - both of which 
were used in several phases of our work - are also presented. 
 
 In Chapter 3, two different approaches (in terms of experimental technique, 
mathematical modeling procedure, and proposed stability model) are applied to the 
measurement of the intrinsic stability parameters of TEM-1 β-lactamase.2 The first 
approach, which uses an array of batch-mode isothermal deactivation experiments to 
generate a rate/temperature/time “landscape”, incorporates the firmly established 
Equilibrium Model theory of enzyme deactivation.3  This model, co-pioneered in 2001 by 
our collaborator Roy M. Daniel, has been used to successfully fit approximately 50 
experimental data sets from nearly 30 tested enzymes.4 Since the model had never been 
tested on TEM-1 β-lactamase, Prof. Daniel kindly hosted me in his lab at the University 
of Waikato in New Zealand in December 2008 so that I could learn first-hand how to 
apply the computational 3-D fitting procedure and to collect data in a manner consistent 
with his previous studies.  At Georgia Tech, I used the same stock of TEM-1 β-lactamase 
to study the enzyme’s stability via a single non-isothermal experiment designed to 
identify the same intrinsic stability parameters as the experiments in New Zealand.  The 
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non-isothermal approach builds upon previous studies by our group on immobilized 
glucose isomerase,5 but i.) adds improvements to the mathematical modeling which better 
reflect the history-dependent aspect of the data ii.) incorporates an enzyme membrane 
reactor (EMR) for the study of soluble (i.e. non-immobilized) biocatalysts and iii.) 
explores the requirement in the case of TEM-1 β-lactamase for a four-state enzyme 
deactivation model versus a three-state model. 
 A heuristic method for quickly estimating the lifetime productivity of a 
biocatalyst at a chosen process temperature is developed in Chapter 4.  A simple 
expression for the total turnover number (TTN), a dimensionless number which is equal 
to the number of moles of product generated by one mole of biocatalyst during its 
lifetime, is rigorously derived from a theoretical framework which assumes no prior 
knowledge of the enzyme’s specific mechanism of deactivation.6 The TTN is perhaps the 
most useful indicator of biocatalyst performance as it can be used to compare lifetime 
productivity across different classes of catalytic technologies (biological, homogeneous, 
heterogeneous). The only data required for the application of our heuristic TTN 
estimation may either be obtained from simple biochemical measurements, or calculated 
from published specific activity and half-life values (provided these two are measured 
under the same conditions, including temperature).  The utility of this method is 
demonstrated by comparing published data for selected enzymes with several similarly 
stable mutants, and predicting how their TTNs will differ.  For the protein engineer who 
must quickly screen several promising enzymes and identify the most cost-effective 
candidate through minimal experimental labor, the heuristic approach is a valuable tool. 
 3
    The non-isothermal modeling approach in an EMR is tested for five stability 
models, each with a different number of potential thermodynamic and/or kinetic 
deactivation routes, with TEM-1 β-lactamase as a test case in Chapter 5.  The newly 
developed heuristic TTN estimation approach is simultaneously applied to this enzyme, 
and the relative strengths of the two methods are compared.  Both methods proved to 
yield reasonable estimates of TTN (well within one order of magnitude) at every point 
within the uppermost 10°C of the enzyme’s effective operating range.  Comparison of the 
five models shows that a four-state stability model with only one kinetically-controlled 
denaturation pathway (from the enzyme’s unfolded state) fits the experimental data better 
than any of the three-state models and just as well as any four-state model with extra 
direct denaturation pathways allowed (i.e. more parameters).  We also establish 
guidelines which simplify the verification of proper reactor design in these non-
isothermal continuous-mode deactivation studies, first by examining the physical 
timescales relevant to the system and then by evaluating the effects of the temperature 
scan rate on the modeled parameters. 
 We conclude in Chapter 6 by considering the overall impact of these two new 
techniques for TTN estimation, and by highlighting some of the future opportunities to 
improve these methods or expand their scope.  In particular, we note that the modeling 
analysis of the continuous non-isothermal experiments could be performed with advanced 
techniques including nonlinear state estimation (to address the issue that reaction rate 
data is actually a proxy for the non-observable concentration of native enzyme in our 
reactor) and these results could be compared to our Euler-type numerical approximation 
in terms of accuracy and computational efficiency.  Furthermore, both the heuristic and 
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modeling methods should be tested on a variety of enzymes, including ones with known 
two- and three-state deactivation mechanisms, to verify the accuracy of the heuristic 
method across deactivation schemes and to assess the power of the accelerated modeling 
method as a diagnostic tool for identifying the appropriate deactivation mechanism in 
cases where it is not known a priori. 
 The principal contribution of this work to the scientific and engineering 
community is that we establish and verify two methods for quickly predicting (within one 
order of magnitude or better) the total lifetime output of a biocatalyst.  One method, 
which is derived from first principles and theoretically independent of the particular 
deactivation mechanism, requires only two simple biochemical measurements: the 
evaluation of the enzyme’s apparent turnover number and of its observed first-order 
deactivation rate constant (which may already be available in the form of specific activity 
and half-life data). The second method uses a single, non-isothermal, continuous 
experiment to estimate physical parameters associated with the enzyme’s activity and 
unfolding via mathematical modeling: parameters which can then be used to predict the 
total lifetime output of the enzyme at any desired temperature without any further 
experimentation.  Both methods eliminate the need for potentially lengthy, expensive, 
and difficult experiments to directly measure the biocatalyst’s yield, under simulated 
process conditions, for the entire useful life of the enzyme.  Overall, this work employs 
the well-practiced framework in chemical engineering of developing a kinetic 
representation of a system, based on a physical model, and applies it to the study of 
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BACKGROUND: OPERATIONAL STABILITY, ENZYME 
MEMBRANE REACTORS, AND TEM-1 BETA-LACTAMASE 
 
2.1  Classical and Recent Models of Protein Stability 
 The simplest view of an enzyme is that of a “lock-and-key” which will 
accommodate certain substrates due to its own specific shape.  If the enzyme’s 
conformation is altered significantly, to the point where the active site residues do not 
properly interact with the substrate molecule, the enzyme can no longer perform its 
function as a catalyst.  The same end result will occur if the enzyme’s active site residues 
become irreversibly bound to an inhibitory agent or if a vital cofactor molecule becomes 
dislodged from the enzyme.  In any case, the enzyme can only be described in one of two 
ways: functional or permanently non-functional.  In this “all-or-nothing” scheme, the 
enzyme is considered to maintain its native state, N, until it becomes denatured (D). 
DN → [2-1] 
 Many decades of observation have shown that some events, particularly protein 
unfolding, which would cause activity to cease may have a reversible character.1-3 When 
the transition to a reversibly unfolded state, U, is the primary cause of deactivation, the 
scheme shown in Equation 2-2 applies. 
[2-2] 
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 Deactivation in general, however, does not necessarily need to be fully reversible.  
Once an enzyme has become unfolded, it may refold to a state which is different, and 
possibly more thermodynamically favorable, than the native conformation. Furthermore, 
proteins which are held under denaturing conditions for longer periods of time have a 
diminished ability to recover their activity.  The stability model set forth by Lumry and 
Eyring in 1954, shown in Equation 2-3, accounts for partial, time-dependent reversibility 
of unfolding.4 
[2-3] 
Importantly, the Lumry-Eyring model captures the notion that the stability of an enzyme 
depends on both thermodynamically-controlled equilibrium (unfolding) and kinetically-
controlled permanent alterations of the protein’s structure based on continued exposure to 
heat (denaturation). 
 Through the past two decades, additional consideration has been given to the idea 
that enzymes can be rendered inactive by events other than unfolding per se.  Even before 
reaching the temperature at which there is a significant degree of unfolded enzyme, as 
evidenced by the loss of secondary structural elements such as α-helices and β-sheets, 
some enzymes exhibit a reversible decrease in apparent activity: a phenomenon which 
cannot be attributed to either of the state transitions in the Lumry-Eyring model.14 The 
consequence is that enzymes can exhibit a temperature optimum which is considerably 
lower than the melting temperature, Tm, associated with unfolding.  To this end, Daniel et 
al. proposed the Equilibrium Model (Equation 2-4), which recognizes that a 
thermodynamic equilibrium may exist between an enzyme’s catalytically active state, 
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Eact, and an inactive (though not necessarily unfolded) state, Einact, which can then 
proceed to a permanently denatured state, X.15 
[2-4] 
 The next logical extension of this theory is that Eact and Einact do not necessarily 
each represent a single state, but possibly an ensemble of states.  The literature shows that 
several proteins including α-chymotrypsin,16 hen egg white lysozyme,17 glutamate 
dehydrogenase,18 β-lactamase,19 and many others exhibit partially unfolded or “molten 
globule” states which maintain a native-like tertiary structure but may or may not be 
catalytically active.20 These folding intermediates have been observed in experiments 
where either heat, pH changes, or agents such as sodium dodecyl sulfate or guanidinium 
hydrochloride were responsible for denaturation.  Treating the molten globule state, M, as 
being in thermodynamic equilibrium with the native state, the corresponding stability 
model is represented by Equation 2-5. 
[2-5] 
 Theoretically, there is no limit to the number of stable intermediates which have 
obtained different degrees of unfolding, and so the multiple intermediate model (Equation 
2-6) presented by Freire et al. may be required in complex cases.21 This model can be 
extended even farther by allowing permanent denaturation pathways from states other 
than the least-structured inactive state, In (to be fully discussed in Chapter 4).  However, 
from the modeling standpoint, the scheme with the fewest intermediates which can still 
accurately reflect experimental observations for a particular enzyme should always be 
selected.  The inclusion of additional states adds extraneous parameters to the model, 
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which is universally expected to improve the quality of fit but could potentially 
undermine the physical significance of the results. 
 
[2-6] 
2.2  Kinetic vs. Thermodynamic Stability of Enzymes 
 Enzymes show an enormous potential for use in biotransformations due largely to 
their specificity and environmentally positive attributes.  However, the limiting factor in 
their application continues to be their relatively low tolerance to conditions which are 
found in many industrial processes (i.e. high temperatures, extreme pH, certain solvents 
and salts).  For the majority of biocatalytic processes, thermal deactivation remains the 
most dominant concern since there are many good reasons to operate at high 
temperatures when possible.  These reasons include, but are not limited to, acceleration of 
the catalyzed reaction, reduction of bacterial contaminants, and higher solubility of key 
reaction components.10 Hence, several strategies have been employed to develop stable 
enzymes which can withstand high temperatures for days or weeks at a time11-13.  As 
noted in Section 2.1, the kinetic stability of an enzyme (ability to maintain near-constant 
specific activity level for long time periods in a given process) does not necessarily 
guarantee its thermodynamic stability (integrity of the active site which directly affects 
the maximum reaction rate), or vice versa, and so factors which affect both types of 




2.2.1  Measurements of Enzyme Stability 
 To assess the intrinsic parameters of deactivation for a particular enzyme, 
transition state theory is often used to describe both the reversible and irreversible 
changes to the enzyme’s conformation.  The kinetic deactivation can be described by an 
Arrhenius Rate Law, shown in Equation 2-7, in which the parameter of interest, Ea, is a 
representation of activation energy of the process which results in irreversible activity 
loss. 
RTEaAek /−= [2-7] 
The most straight-forward manner to calculate Ea experimentally is to conduct an array 
of isothermal deactivation experiments at several different temperatures.  Provided the 
deactivation follows an overall first-order behavior with respect to time, the value of k 
(here termed kD) can be determined at each temperature; a typical experimental result is 
shown in Figure 2-1. 
 
Figure 2.1  First-order kinetic deactivation of enzyme from residual activity plot. 
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 From a sufficient number of isothermal experiments, one can construct an 
Arrhenius plot (ln k vs. 1/T) which has a slope of - Ea/R, where R is the gas constant. The 
main limitation of this approach is that the collection of deactivation data at several low 
temperatures, which is necessary to construct a proper Arrhenius plot, can require 
experiments of very long duration.  Also (and most importantly from the standpoint of 
our studies) the observed kD at each different temperature in the Arrhenius plot could be 
affected by the degree of thermodynamic unfolding of the enzyme, and would thus need 
to be corrected by the associated equilibrium constants, which are not always 
immediately available. 
 There are also some established experimental techniques for estimating the 
thermodynamic unfolding parameters of an enzyme, most notably differential scanning 
calorimetry (DSC) and circular dichroism (CD) spectroscopy.  The unfolding behavior of 
an enzyme can be described by Equation 2-8, derived from the Gibbs-Helmholtz 
equation.32 
[2-8] 
The parameters of Equation 2-8 include the enzyme’s melting temperature, Tm, the 
enthalpy change associated with the unfolding transition, ΔHm, and the change in heat 
capacity between the native and unfolded forms of the protein, ΔCp. The values of these 
parameters can be measured via DSC, which operates by independently heating two 
sample cells (one with enzyme and one with empty buffer) such that their temperature 
remains identical, and measuring the difference in power input to the two cells.  A typical 
DSC scan is shown in Figure 2.2.   
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Figure 2.2  Experimental measurement of thermodynamic stability parameters. (A) 
Unfolding progress curve derived from CD data. (B) Use of differential scanning 
calorimetry to study unfolding.36 
 
 The melting temperature, Tm, can also be estimated through the use of CD, which 
detects the change in ellipticity at the specific wavelengths associated with protein 
secondary structures (for example, 222 nm for α-helices) as a sample is continuously 
heated. The ellipticity data can be used to determine the degree to which secondary 
structure has been lost at any point during the temperature scan, such that the fraction of 
enzyme which has unfolded may be plotted against temperature (Figure 2.2).  The Tm is 
found at the midpoint of the transition, corresponding to 50% unfolded enzyme. 
 Both DSC and CD are useful for determining the intrinsic unfolding parameters of 
enzymes, but they both carry certain limitations with regards to predicting the complete 
operational stability of an enzyme. Both methods only give information related to the 
unfolding, and to reiterate, not all enzymes maintain active site integrity up to the point of 
unfolding.  Small changes in the tertiary structure, which would be difficult or impossible 
to detect by either CD or DSC, can change the orientation of active site residues such that 
catalytic activity is lost.  A direct correlation between unfolding and activity cannot be 
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made unless the enzyme unfolds in a highly cooperative manner.  Furthermore, the 
observed parameter values from both DSC and CD exhibit dependence upon the 
temperature scan rate of experiments, as different degrees of cumulative denaturation 
during the course of the scan can affect the results.  This once again reinforces the notion 
that both thermodynamic and kinetic phenomena must be considered in any proper 
discussion of enzyme stability. 
2.2.2  Operational Stability and the Total Turnover Number 
 The Arrhenius Rate Law (Equation 2-7) applies not only to deactivation 
phenomena, but also to the dependence of the enzyme-catalyzed reaction rate on 
temperature.  Theoretically, an increase in temperature will be accompanied by an 
exponential increase in the rate of the desired reaction, yet that same temperature increase 
will render the enzyme itself less stable.  Therefore, there are two competing effects 
which dictate the productivity of the enzyme.  In terms of process design, each 
biocatalyst will have an optimum temperature at which the heightened specific activity 
and the present degree of enzyme deactivation result in the maximum substrate turnover.  
The “optimum temperature”, Topt, typically refers to the point at which the 
instantaneously measured activity reaches its maximum value.  Figure 2.3 illustrates the 
typical instantaneous temperature optimum of an enzyme, with a steady increase in 
activity until the enzyme reaches its melting temperature, Tm, after which the observed 
activity decreases sharply.  This conceptualization only considers the thermodynamic 
stability of the enzyme. 
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Figure 2.3  Instantaneous temperature optimum. 
 In a process lasting days or weeks, kinetically-controlled mechanisms of 
deactivation become highly important.  The temperature which produces the highest 
specific activity will not necessarily result in the highest yield over the lifetime of the 
enzyme.  In fact, our recent work indicates that as temperature is decreased, the total 
output of the enzyme will continue to increase even though the reaction rate becomes 
much slower.  At some point, minimum rate requirements must be imposed to achieve an 
economical process.  Therefore, when considering the conditions and the duration of a 
given process, the true temperature optimum (in terms of yield) will occur at a 
temperature lower than the instantaneous Topt, as seen in Figure 2.4. 
 One particularly useful indicator of the lifetime productivity of a biocatalyst is the 
total turnover number (TTN) which is mentioned frequently in the following chapters.  
The TTN, by definition, is the number of catalytic events which a single molecule of 
biocatalyst conducts during its entire lifetime (i.e. until it is irreversibly inactivated).  An 
alternative, macroscopic definition is that TTN equals the number of moles of product 
yielded by one mole of biocatalyst before it becomes depleted.  Either definition results 
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in TTN being a dimensionless number.  Experimentally, TTN can be defined as the area 
under the curve of a reaction rate vs. time plot for a given biocatalyst, divided by the 
initial concentration of enzyme placed into the system. 
 
Figure 2.4  Optimum process temperature of a biocatalyst. 
 The use of TTN as a productivity indicator has two key advantages.  Firstly, it is 
very straightforward to implement TTN in costing estimations as it directly scales the 
operating cost of enzyme consumption to the revenue from the product.  Secondly, TTN   
can be used to compare lifetime productivity across different classes of catalytic 
technologies (biological, homogeneous, heterogeneous). 
2.3  TEM-1 β-Lactamase 
 The enzyme chosen as a test case for the present study was the TEM-1 form of the 
well-studied enzyme, β-lactamase.  The β-lactamases are well-known for their role in 
bacterial resistance to β-lactam antibiotics and their clinical importance has led to 
thorough study of their structure and mechanisms over nearly 75 years.5 Though there are 
presently no large-scale industrial bioprocess applications for this enzyme, it was selected 
for our deactivation studies due to a variety of reasons to be discussed in this section. 
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2.3.1  Characteristics 
 The β-lactamases are a family of enzymes which, as their name implies, 
demonstrate activity toward hydrolysis of the β-lactam bond found in the core structure 
of penicillin-based antibiotics.  The reaction scheme involving a well-known antibiotic 
molecule, penicillin G (benzylpenicillin) is shown in Figure 2.5. 
 
Figure 2.5  Enzymatic hydrolysis of penicillin G.  β-lactam bond indicated by small 
arrow on substrate. 
 
 Three of the four classes of β-lactamases (A, C, and D) are serine proteases, while 
Class B metallo-β-lactamases (which are few in number) require a Zn++ cofactor. TEM-1 
β-lactamase (E.C. 3.5.2.6) is a Class A β-lactamase with a sequence length of 286 AA 
and a molecular mass of 31,515 Da.  It is the most common plasmid-mediated β-
lactamase found in gram-negative bacteria; its designation as a Class A β-lactamase 
means that it shows activity toward penicillin and is inhibited by clavulanic acid.22,23 The 
catalytic pathway of TEM-1 involves acylation of the active serine (Ser-70) followed by 
the hydrolysis of the resulting ester bond and proton transfer to the carboxylate group of 
Glu-166 either directly or via a water molecule.24 The crystal structure of TEM-1 β-
lactamase at 1.55Å resolution25 (PDB: 1ZG4) along with a detailed view of the active 
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site26  is shown in Figure 2.6 and the protein sequence (UniProt Knowledge Base, 








Figure 2.6  Crystal structure of wild-type TEM-1 β-lactamase from E. coli with active 




Figure 2.7  Protein sequence of mature TEM-1 β-lactamase from E. coli. 
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 TEM-1 β-lactamase has evolved to function under physiological conditions of 
37°C but shows limited stability at higher temperatures.  Its published melting 
temperature, Tm, as indicated by CD spectroscopy, is 51°C.27 Toward the natural 
substrate penicillin G, TEM-1 β-lactamase is considered to be a relatively efficient 
catalyst, with a published kcat/KM  ratio of 9.24 x 106 M-1 s-1 at 25°C, pH 7.0 in 50 mM 
potassium phosphate buffer.28 The diffusion-controlled limit for enzyme-catalyzed 
reactions in aqueous solution is approximately 109 M-1 s-1. 
2.3.2  Choosing TEM-1 as a Test Case 
 For the purposes of our thermal deactivation studies, TEM-1 β-lactamase was 
chosen as the test case for a multitude of reasons.  The fact that it is a monomeric enzyme 
eliminated concerns about the effects of subunit dissociation on the observed activity and 
stability upon heating. There are no required cofactors in the catalytic action of TEM-1 β-
lactamase, so the experimental design was not complicated by cofactor concerns. Many 
cofactors are quite expensive and it would have been highly impractical to use an enzyme 
which requires one in our long-term continuous studies.  Furthermore, any potential 
changes in cofactor binding at elevated temperatures would need to be addressed, which 
would compound the complexity of the non-isothermal modeling analysis.  The 
availability and low price of the enzyme’s natural substrate, penicillin G, was also a clear 
benefit. 
 The mesophilic character (moderate thermal stability) of the wild-type TEM-1 β-
lactamase made it more practical for use in the accelerated TTN modeling approach.  
Though the modeling approach should work equally well for a hyperthermophilic 
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enzyme (and indeed should be the approach of choice in such cases), the corroboration of 
the models by direct measurement becomes exceedingly difficult with an engineered 
commercial biocatalyst which is stable for weeks or months even at temperatures in the 
vicinity of 90°C, as noted in previous work.33 
 Our early observations indicated that TEM-1 β-lactamase unequivocally obeys a 
stability model other than the simple two-state mechanism shown in Equation 2-1, as 
partial recovery of activity was observed after subsequent heating and cooling.  We also 
noted that the enzyme activity versus temperature profile did not increase exponentially 
at moderate-to-low temperatures, which led us to believe that the active site was 
somehow becoming compromised far below the published Tm and that the application of 
the Equilibrium Model should be considered.15 TEM-1 and other Class A β-lactamases 
has been shown to exhibit four-state unfolding behavior in chemical denaturation studies 
with guanidinium hydrochloride - having a stable “molten globule” intermediate which 
precedes the completely unfolded state.19,34,35 Therefore, this enzyme presented an 
interesting case with which to analyze models of different complexity in a complete 
operational stability study.  
2.3.3  Expression and Purification 
     The DNA sequence encoding wild-type TEM-1 β-lactamase was cloned into the 
pET-27b(+) vector (EMD Biosciences - Gibbstown, NJ) and used to transform an aliquot 
of E. coli BL21 (DE3) competent cells.  The cells were incubated for 24 h at 30°C on a 
kanamycin-infused agar plate and a single colony was picked to generate a stock of 
transformed cells.  A 1-mL sample of the transformed cell stock was used to inoculate 
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200 mL of the expression medium, which consisted of LB-Miller broth with 0.3 M 
sorbitol and 2.5 mM betaine (osmolytes to enhance medium secretion)7 and 35 μg/mL 
kanamycin sulfate.  The culture was incubated at 37°C in a 1.0 L Erlenmeyer flask, 
agitated at 120 rpm, until an OD600 of 0.8 was reached; at this point over-expression was 
induced by the addition of 0.3 mM isopropyl β-D-1-thiogalactopyranoside (IPTG).  The 
induced culture was incubated for 16 h at 25°C, with 120 rpm agitation, after which the 
cell debris was removed by centrifugation at 5100 g for 30 minutes (Model J6M 
centrifuge, Beckman-Coulter - Brea, CA).  The resulting yield of cells (dry cell weight) 
was 2.2 g/L. 
 The clarified medium (supernatant) was chilled to 4°C and mixed with saturated 
ammonium sulfate solution (also at 4°C) to a final salt level of 55% saturation (2.16 M).  
After incubation for 1 h at 4°C, the precipitated solids were removed by centrifugation at 
5100 g for 60 minutes and discarded.  The supernatant was brought to 90% ammonium 
sulfate saturation (3.55 M) by addition of more salt solution, and incubated for 1 h at 4°C.  
The precipitated solids were collected by centrifugation at 5100 g for 60 minutes and 
resuspended in 10 mL of 20 mM Tris-HCl buffer at pH 8.2; the recovered fraction was 
dialyzed for 16 h at 4°C in 3 L of the same Tris-HCl buffer using Spectra/Por® cellulose 
tubing (Spectrum Labs - Rancho Dominguez, CA) with a MWCO of 3.5 kDa. After 
dialysis, the retained protein sample was passed through a 0.2 μm sterile polyethersulfone 
syringe filter (VWR - West Chester, PA). 
 The filtered sample was purified by anion exchange chromatography using an 
ÄKTAexplorerTM 100 system (GE Healthcare - Piscataway, NJ) equipped with a 5-mL Q 
SepharoseTM XL column; 20 mM Tris-HCl buffer at pH 8.2 was used as the running 
 21
buffer and a linear gradient of 0-0.5M NaCl was applied over 50 column volumes.  The 
resulting fractions were assayed for activity using the CENTA assay (see Subsection 
2.3.4.1) and the single 5-mL eluted fraction with the highest specific activity was 
collected and used for further study.  Immediately following purification, the enzyme 
showed a specific activity of 118 U/mg toward the CENTA chromogenic substrate (assay 
conditions are 25°C, pH 7.0, 50 mM sodium phosphate buffer).  Multiple batches of 
enzyme were used throughout the course of these studies, but the initial activity of the 
purified enzyme never differed from this value by +/- 10%, or else the protein was 
discarded and the purification repeated. 
 
 Figure 2.8  SDS-PAGE analysis of TEM-1 β-lactamase purification. 
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 The ammonium sulfate precipitation and anion exchange chromatography steps 
had activity yields of 87.6% and 40.2%, respectively.  The expression level in the media 
before any purification steps was 7.3 U/mL (83.8 U/mg) for a final purification level of 
1.41-fold and an overall yield of 35.2%. The use of SDS-PAGE confirmed the high level 
of purity of the final protein sample, as shown in Figure 2.8, using a PreciseTM 12% 
Protein Gel (Pierce - Rockford, IL) and an unstained Precision PlusTM protein standard 
marker (Bio-Rad - Hercules, CA).  The gel was stained with GelCode BlueTM solution 
(Thermo Scientific - Rockford, IL).  The initial (crude expression media) and final 
(purified fraction) lanes were overloaded to more clearly show the change in purity. 
2.3.4  Activity Assays 
2.3.4.1  CENTA 
 The chromogenic substrate CENTA (CAS # 9073-60-3) is a commercially 
available substance, derived from the antibiotic cephalothin, used for the screening of β-
lactamase activity.  The structure is shown in Figure 2.9. The compound has a neutral 
yellow color in aqueous solution, and upon hydrolysis of the β-lactam ring by the 
enzyme, changes noticeably to a pale, bright yellow.  The literature reports that the 
change in extinction coefficient of CENTA upon hydrolysis is Δε = -6400 M-1 cm-1 at 
405 nm and that the KM value of TEM-1 β-lactamase toward CENTA is 70 μM at 30°C, 
pH 7.0, in 50 mM sodium phosphate buffer.6 
 A CENTA concentration of 500 μM (in 50 mM sodium phosphate buffer, pH 7.0) 
was used in the activity assay in order to stay well above the KM value; unfortunately this 
resulted in a starting absorbance of over 3 AU.  The UV/visible spectrophotometer used 
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in our study (model DU-800, Beckman-Coulter - Brea, CA) was near the limit of signal 
saturation at this level, as most similar instruments would be, and the data would have 
been considered unreliable.  Rather than lowering the CENTA concentration and risking 
an unsaturated condition for the enzyme, we shifted the analytical wavelength to 460 nm 
where the change in extinction coefficient upon hydrolysis was found to be Δε = -2370 
M-1 cm-1 (25°C, pH 7.0, 50 mM sodium phosphate buffer) and the starting absorbance 
was only 1.2 AU.  The value of Δε460 was confirmed by performing triplicate dilution 
series at seven different concentrations; the R2 value for the linear fit of the absorbance 
vs. [CENTA] data exceeded 0.999.  Using 750 μL of the 500 μM stock solution per 
assay, along with a 10-μL sample containing approximately 100 ng of enzyme, resulted 
in pseudo-zero order kinetics and allowed for simple calculation of reaction rate from raw 
absorbance data. 
 
Figure 2.9  Chemical structure of CENTA β-lactamase substrate. 
 The CENTA assay was very useful in verifying the success of protein purification 
runs, but was not pursued as a test substrate during the deactivation studies.  The primary 
factors in choosing an alternate substrate were 1.) the significant level of background 
thermal degradation of CENTA at temperatures above 45°C 2.) the relatively high cost 
($7.25/mg) which would have made long-term continuous experiments prohibitively 
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expensive and 3.) lack of access to an open-loop continuous flow spectrophotometer 
which could be attached to our reactor.  Another commonly used chromogenic substrate, 
nitrocefin8 ($18.20/mg), was ruled out for these same reasons. 
2.3.4.2  Penicillin G (spectrophotometric) 
 For the arrays of isothermal deactivation studies performed in conjunction with 
the Equilibrium Model studies done in New Zealand (see Chapter 3), a 
spectrophotometric method was developed to measure the activity of TEM-1 β-lactamase 
toward its natural substrate, penicillin G.  As with the CENTA assay described in 
Subsection 2.3.4.1, the analytical wavelength (and in this case, also the cell path length) 
was chosen such that a sufficiently high substrate concentration could be used in order to 
stay well above KM, without pushing the measured absorbance values above 1.5 AU 
where the accuracy of the spectrophotometer may be compromised. 
 The reaction mixture consisted of an aqueous solution of 50 mM sodium 
phosphate buffer and 4.4 mM penicillin G at pH 7.0. An analytical wavelength of 252 nm 
was chosen, at which the penicillin G exhibited an extinction coefficient of ε252 = 682 M-1 
cm-1 and the fully hydrolyzed mixture exhibited an extinction coefficient of ε252 = 213   
M-1 cm-1 as evidenced by the linear fits (R2 = 0.995) of triplicate dilution series from       
0-4.4 mM in increments of 0.44 mM.  This absorbance difference Δε of 469 M-1 cm-1 
between the substrate and product remained constant throughout the entire temperature 
range of the studies.  The sample cell was a quartz cuvette with a path length of 0.5 cm, 
which gave a starting absorbance of 1.5 AU. 
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2.3.4.3  Penicillin G (polarimetric) 
 All experiments involving the EMR as well as the batch-mode enzyme activity 
profiles and deactivation studies performed at Georgia Tech used our novel polarimetric 
penicillin G assay.  The experiments were performed on an Autopol II polarimeter 
(Rudolph Research Analytical - Hackettstown, NJ) equipped with either a static, 
temperature-jacketed 8.5-mm ID x 10-cm path length sample cell (for batch-mode 
experiments) or a flow-through, temperature-jacketed 2.5-mm ID x 10-cm path length 
sample cell (for continuous-mode experiments). 
 To achieve a good signal-to-noise ratio from the polarimeter, which had a 
precision level of +/- 0.01°, the assay was designed to have a starting optical rotation 
value above 2.0°.  The penicillin G substrate exhibited a specific optical rotation of 
107° M
25α 589][
-1 at 25°C in 50 mM sodium phosphate buffer, pH 7.0, according to the results of 
a triplicate dilution series.  Hence, a substrate concentration of 20 mM was chosen for the 
assay solution. 
 The presence of the hydrolysis product, D-benzylpenicilloic acid, induced 
significant pH changes after 100% substrate conversion by the enzyme in 50 mM sodium 
phosphate buffer at pH 7.0.  Therefore, the substrate-to-buffer ratio was optimized to 
maintain a constant pH throughout the range from 0-100% conversion.  A solution of 20 
mM penicillin G in 200 mM sodium phosphate buffer, with a starting pH of 7.05, was 
found to maintain a pH of 7.0 +/- 0.1 at all levels of conversion and all temperatures in 
the range of 20-60°C. 
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 The hydrolysis product is itself chiral and has also been reported to be prone to 
thermal degradation9, so its observed optical rotation was expected to be non-zero and 
possibly variable through our temperature range of interest.  A calibration curve was 
constructed by first flowing substrate solution through the EMR (see Section 2.4 for 
details of the reactor) at a flow rate of 1 mL/min (for a reactor residence time of 10 
minutes) with no enzyme present.  The temperature of the reactor was increased from 
20°C to 60°C at a rate of 4°C/h and the optical rotation of the reactor effluent was 
recorded at 25°C to assess the background thermal degradation of the substrate.  Next, the 
EMR was overloaded with 1 mg of enzyme (over 100x the amount needed to observe full 
conversion at this residence time) and subjected to the same scan from 20°C to 60°C.  
 Unlike the substrate, which showed only very slight change in optical rotation, the 
product showed a monotonically decreasing trend as the temperature increased to 55°C.  
At 55°C, the trend suddenly reversed due to the fact that all of the enzyme had become 
deactivated, so this curve was truncated at 55°C.  The calibration curve is shown in 
Figure 2.10.  As the calibration curve shows, the 0% conversion data could be fitted to a 
straight line with a very slight negative slope, and the 100% conversion curve could be 
fitted to a second-order polynomial with temperature as the parameter.  Thus, in all 
continuous EMR experiments, the proportion of substrate conversion, X, could be 













Figure 2.10  Polarimetric assay calibration curve. 
 The reaction rate in mol L-1 s-1, when the reactor is operated as a continuous 
stirred-tank reactor (CSTR) is given by Equation 2-10, where the substrate concentration 
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Similarly, for batch mode experiments in which the substrate concentration was not held 
constant in the sample cell (though still in large excess and well above the KM of the 
enzyme, i.e. pseudo-zero order), the reaction rate in mol L-1 s-1 was calculated from the 












dTr θ   [2-11] 
2.4  Enzyme Membrane Reactor 
 The enzyme membrane reactor (EMR) used in continuous experiments for this 
study consisted of a temperature-jacketed stainless steel vessel with built-in temperature 
jacket (EDS Maschinebau - Linnich, Germany) and an effective volume of 10.0 mL, 
excluding the internal PTFE-coated magnetic stir disc.  The enzyme (with its molecular 
weight of 32 kDa) was retained in the reactor by an Amicon 63.5-mm diameter 
polyethersulfone membrane with a MWCO of 5 kDa, while substrate and products were 
able to pass through to the permeate side of the reactor.  This type of membrane was 
chosen for its favorable temperature and pressure ratings (65°C, 70 psi) and the low 
protein binding of polyethersulfone as compared to regenerated cellulose or cellulose 
acetate membranes.  The enzyme was used in its soluble form, requiring no 
immobilization for use in this reactor. 
 Feed solution was supplied to the reactor from a refrigerated tank via a digitally 
programmable peristaltic pump with ratcheted pressure control (ISMATEC Model CP 
70817-10 - Glattbrugg, Switzerland).  The temperatures of the reactor jacket and the 
polarimeter sample cell were controlled independently by two water baths with built-in 
programmable digital controllers (Model 1167, PolyScience - Niles, IL).  The fluid 
temperature within the reactor jacket was monitored during experiments with a 
Traceable® dual channel thermometer (VWR - West Chester, PA) with a Type-K 
beaded-probe thermocouple, equipped with an RS-232 output for continuous data 
recording by PC.  The total dead volume between the reaction chamber and the 
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polarimeter sample cell (consisting of the perforations in the membrane support disk and 
the small-bore outlet tubing) was 300 μL such that there was only a minimal time delay 
(20 s at the flow rate of 1 mL/min) in the recorded optical rotation data. Schematic 
diagrams of the reactor vessel and the complete experimental setup are shown in Figures 
2-11 and 2-12, respectively. 
 
Figure 2.11  Enzyme membrane reactor (EMR) diagram. 
 
 
Figure 2.12  Experimental setup for EMR deactivation studies. 
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2.4.1  Theory of CSTR Operation 
 The simplest method for extracting reaction rate data from the measured 
concentration of the reactor effluent stream is to operate the EMR as a continuous stirred-
tank reactor (CSTR).  Theoretically, an ideal CSTR contains no dead volume, 
temperature or concentration gradients, or other mixing irregularities and the composition 
of the effluent stream is identical to that of the (homogeneous) contents of the reactor.  In 
the case of an ideal CSTR, the residence-time distribution function, E(t), which describes 
how much time fluid elements spend inside the reactor, is given by Equation 2-12. 
τ
τ
/1)( tetE −=          [2-12] 
A perfectly-mixed reactor which initially has an initial concentration, C0, of some 
observable species and is then subjected to a sudden step change in the feed concentration 
of that same species will obey Equation 2-13. 
τ/
0)(
teCtC −=            [2-13] 
Therefore, a step tracer input test was used to determine whether the EMR in our study 
can be considered an ideal CSTR. A step input tracer test was conducted, in which the 
feed (1.0 mL/min flow rate) was instantly switched from 20 mM penicillin G in 200 mM 
sodium phosphate buffer to a penicillin-free solution of the same buffer (optical rotation 
of zero).  A linearized plot of ln C(t)/C0 vs. time was constructed, and the measured slope 
(- 1/τ) resulted in a calculated reactor volume of 10.02 mL (nearly identical to the 
measured volume.  When these two volumes agree, CSTR behavior is confirmed.   
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 Equation 2-13 can be used to describe the time delay of a CSTR in achieving 
steady-state composition of the reactor contents.  As a general rule of thumb, the time for 
steady state to be reached, tss, is equal to five times the calculated residence time of the 
CSTR. The rule of thumb arises from setting the requirement that the observed change in 
tracer concentration at the reactor outlet has reached a value that is 99% of the actual step 
change in the feed stream concentration. At such a point, C(t)/C0 = 0.01 and the 
associated time calculation is shown in Equation 2-14. 
τττ 561.4)01.0(ln ≈=−=sst     [2-14] 
2.4.2  Control Measures 
 Once CSTR behavior was confirmed, certain measures were taken to ensure the 
smooth operation of the reactor through both the temperature ramp and isothermal 
experiments.  Foremost, it was observed during control runs at 4°C (where no observable 
kinetic deactivation was found) that the apparent activity of the enzyme consistently fell 
to undetectable levels within 36 h. The activity decrease exhibited clear first-order 
behavior with a half-life of approximately 2 h.  The membranes were inspected for 
physical damage and none was found; furthermore, the choice of such a low MWCO 
rating (the enzyme is six times the size of the nominal cutoff) led us to rule out the 
likelihood of leakage of the enzyme through the membrane.  The stirring speed of the 
internal Teflon-coated magnetic disc had already been optimized to a range (100-180 
rpm, impeller diameter 6.5 cm) where CSTR behavior was maintained but cavitation 
bubbles were not found to form underneath the membrane (i.e. shear was kept to a 
minimum). 
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 The adsorption of enzyme to the membrane was implicated as the cause of the 
apparent deactivation.  A test was conducted in which 1 mg/mL of bovine serum albumin 
(BSA) - a 66 kDa inert protein with zero catalytic activity toward penicillin G - was 
injected into the reactor and mixed for one hour before the addition of the β-lactamase.  
The BSA was intended to block the catalyst from adsorbing the membrane surface, and 
the results in Figure 2.13 show conclusively that this was a necessary measure. 
 
Figure 2.13   Results of BSA addition to prevent catalyst adsorption to membrane. 
 
 Though the geometry of the reactor interior with its relatively large heat transfer 
area ensured a lack of temperature gradient within the reactor (and this is corroborated by 
the demonstration of ideal CSTR behavior), we observed a slight temperature 
discrepancy between the programmed set point of the temperature bath and the reactor 
jacket/interior.  This difference was due to heat loss through the stainless steel walls to 
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the environment, and became larger at temperatures farther from ambient.  However, 
even at the heat transfer timescale of a 12 K/h temperature ramp, the temperature inside 
the reactor maintained its intended linear profile, as shown in Figure 2.14.  The 
discrepancy between the reactor interior and the programmed set point versus 
temperature at all ramp rates is shown in Figure 2.15. 
 
Figure 2.14  Reactor jacket temperature vs. water bath set point, 12 K/h ramp. 
2.4.3  Reactor Timescale Considerations 
 Prior to performing modeling analysis on reaction rate data from the EMR, we 
considered the relevant timescales that could affect the measured output from the reactor.  
As a general rule, the phenomenon which is under investigation should always be the 
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rate-limiting step which controls the observed signal. In the case of enzyme stability 
testing, the timescale for the deactivation of the enzyme should be the longest one.  In the 
scale-up of reactors used in bioprocesses, some important characteristics times are 
commonly assessed: diffusion, heat transport, oxygen transport, mixing, flow, microbial 
growth, chemical reaction, among others.  Several of these do not apply to our small-
scale reactor with soluble enzyme used in place of live microbes, but four of them 
potentially do.  Heat transport, mixing, flow, and chemical reaction were all identified as 
phenomena which could impact the performance of the EMR, and so the timescale of 
each was evaluated using the physical parameters of our system and the published 
equations for stirred-tank reactors.30  
 
Figure 2.15  Deviation of reactor temperature from water bath set point, all ramp rates. 
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 The chemical reaction timescale was calculated after activity measurements were 
made on TEM-1 β-lactamase and the value was found to be very small (τrxn = 48-590 μs) 
over the experimental temperature range (these results are explained fully in Chapter 5). 
The characteristic time for the heat transport process in a stirred vessel is given by 2-15, 
where V is the reactor volume, ρ  is the density of the fluid in the reactor, Cp is the heat 
capacity of the fluid in the reactor, A is the contact area between the temperature jacket 





τ =              [2-15] 
The value of U was calculated for this system by assuming the values of the heat transfer 
coefficients for the heating water in the temperature jacket and the stirred contents of the 
reactor to be h = 500 W/m2K (both are aqueous solutions in the turbulent flow regime).  
Using the wall thickness of the reactor, xW = 0.6 cm, and the thermal conductivity of 

















U    [2-16] 
Hence, with V = 10 mL, ρ = 1 g/mL, Cp = 4186 J/kgK, and the measured contact area of 
A = 38.5 cm2, the value of τht was found to be 47 s for this system. 
 The characteristic time for mixing in the stirred vessel, τmix, is given by Equation 
2.17, where V = reactor volume, N = impeller rotation number, and D = impeller 
 36
diameter.  With V = 10 mL, N = 3 s-1 (at the typical 180 rpm setting), and D = 6.5 cm, the 





mix =τ            [2-17] 
 The timescale for flow in a stirred tank is simply given by τflow = V/ν  where ν is 
the volumetric feed flow rate.  In a CSTR, the value of τflow is, by definition, equal to one 
reactor residence time.  In all of our EMR experiments, V = 10 mL and ν = 1.0 mL/min, 
hence τflow = 10 min.  Of all the timescales we considered, τflow was by far the longest and 
therefore the most likely to interfere with data collection under reactor conditions where 
enzyme deactivation is rapid. If necessary, this could be remedied by increasing the feed 
flow rate, thereby shortening the residence time, provided that i.) pressure limitations of 
the EMR membrane are not exceeded and ii.) τflow is longer than both τht and τmix (a 
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DEACTIVATION OF TEM-1 β-LACTAMASE INVESTIGATED BY 
ISOTHERMAL BATCH AND NON-ISOTHERMAL CONTINUOUS 
ENZYME MEMBRANE REACTOR METHODS 
 
3.1  Introduction 
 The thermal deactivation of TEM-1 β-lactamase was examined using two 
experimental techniques: a series of isothermal batch assays and a single, continuous, 
non-isothermal assay in an EMR. The isothermal batch mode technique was coupled with 
the three-state Equilibrium Model of enzyme deactivation, while the results of the EMR 
experiment were fitted to the four-state “molten globule” model. The two methods both 
led to the conclusions that the thermal deactivation of TEM-1 β-lactamase does not 
follow the Lumry-Eyring model and that the Teq of the enzyme (the point at which active 
and inactive states are present in equal amounts due to thermodynamic equilibrium) is at 
least 10°C from the Tm (melting temperature), contrary to the idea that the true 
temperature optimum of a biocatalyst is necessarily close to the melting temperature.6,27 
3.1.1  The Equilibrium Model and Isothermal Applications 
 The operational stability of a biocatalyst is an important characteristic in 
determining the suitability of that catalyst in a given process. It is well-understood that 
catalytic activity tends to increase with temperature, but that in the case of enzymes, 
elevated temperature also leads to thermal deactivation due to a loss of integrity of the 
active site.1,2 When kept at elevated temperatures for extended time periods, enzymes will 
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undergo denaturation to a permanently inactive state. Some enzymes are capable of 
recovering catalytic activity after relatively short incubations at elevated temperatures 
which induce a loss of activity.3,4 The Equilibrium Model (Figure 3.1) captures this 
phenomenon by including a reversible transition between active and inactive states, and 
has been shown to be valid for all of the enzymes (at least thirty at present) on which it 
has been tested.5–8 
 
 
Figure 3.1  Equilibrium Model. 
 
 By treating the reversible transition between Eact and Einact as a van’t Hoff-type 
equilibrium, and the transition from Einact to X as a time-dependent, first-order decay with 
Arrhenius-type rate constant, one can derive an expression for the observed reaction rate 
as a function of temperature and elapsed time.5,6 Transition state theory is utilized to 
define the three quantities involved in the deactivation model, according to Equations 3-1 
to 3-3. These are kcat (turnover number of enzyme), Keq (equilibrium constant between 
Eact and Einact), and kinact (first-order rate constant for decay from Einact to X). The 
description of the Einact to X step in the Equilibrium Model is not intended to preclude the 
presence of multiple, inactive intermediate unfolding states, though it makes no 
distinction between such states.8 
 










Tkk catBcat exp  
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Tkk inactBinact exp [3-3] 
 
 Under isothermal conditions, the values of kcat, Keq, and kinact remain fixed, and 
depend only on the activation and deactivation parameters of the enzyme at that 
temperature: ΔGcat (activation energy for enzyme catalyzed reaction), ΔGinact (activation 
energy for the Einact to X transition), ΔHeq (enthalpy change for the Eact to Einact 
transition), and Teq (temperature at which [Eact] = [Einact]). When isothermal conditions 
exist, the expression for the reaction rate Vmax, as a function of temperature and time, is 

































max  [3-4] 
 
 By substituting the results of Equations 3-1 to 3-3 into Equation 3-4, the values of 
ΔGcat, ∆Ginact, ∆Heq, and Teq may be estimated by fitting experimental data of reaction 
rate vs. temperature vs. time to the model.9 The established method for estimating these 
parameters is to perform an array of activity progress curves (including isothermal 
deactivation), while holding E0 constant. After several temperatures have been examined, 
all progress curves are fitted to a three-dimensional surface plot using Powell’s algorithm 
to determine the global minimum of the sum of squares deviation between the 
experimental curves and the model.9 
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3.1.2  The “Molten Globule” Model and Temperature Ramps 
 Recently, a method was developed for determining the optimum operating 
temperature for a biocatalyst using a single, continuous assay rather than an array of 
isothermal experiments.10,11 This method utilizes an EMR for soluble enzyme, or a 
packed-bed reactor for immobilized enzyme, to subject a single sample of enzyme to a 
continuous, positive, most often linear temperature gradient. Since time and temperature 
are functionally related in such a linear ramp scheme, the reaction rate may be expressed 
as a function of a single variable (either time or temperature), plus all of the intrinsic 
activation and deactivation parameters listed in Equations 3-1 to 3-3. 
 As certain enzymes are known to lose catalytic activity before the onset of 
complete unfolding (i.e. the global loss of secondary structure often associated with the 
Tm of the enzyme),1 the model used with the continuous temperature ramp experiment 
assumes that the biocatalyst follows a four-state deactivation model. This four-state 
model is similar to the Equilibrium Model but allows for two separate inactive states. The 
native state, N, is in equilibrium with a “molten globule” state, M, which has undergone 
slight conformational changes that render it inactive. For some enzymes including 
chorismate mutase, the molten globule state does undergo changes in tertiary structure 
but remains catalytically active,28 but in our model M was considered inactive. Herein, 
states N and M are taken to be functionally equivalent to Eact and Einact, respectively, in 
the Equilibrium Model. The four-state model includes a second equilibrium between M 
and an unfolded state, U, which has unfolded in the sense that it has experienced a 
widespread loss of secondary structure. This “molten globule” unfolding model is shown 




Figure 3.2  “Molten globule” model. 
  
 The “molten globule” unfolding model assumes that the enzyme must first enter 
the unfolded state U before it may become permanently denatured and that there are no 
pathways for denaturation directly from the native or molten globule states. It uses the 
same parameter as the Equilibrium Model, Keq, to describe the van’t Hoff equilibrium 
between states N and M. The first-order denaturation constant for state U, kinact, is also 
the same for both models. The molten globule model, however, contains the additional 
parameter, Kmg = [U] / [M], shown in Equation 3-5, where Tmg is the temperature at 






























 Hence, the four-state model assumes a heterogeneous population of inactive 
enzyme and seeks to capture both the Teq and the traditional Tm of the enzyme. Both of 
these values, which do not necessarily coincide with each other, are important when 
designing and characterizing a stable biocatalyst.8 When biocatalyst deactivation data is 
collected in a system which is operated as a continuous stirred-tank reactor (CSTR), the 

















 Equation 3-6 contains the system parameters V (reactor volume), [S]0 (substrate 
feed concentration), and ν (feed volumetric flow rate). Both kcat and [N] vary over the 
course of the experimental run as temperature is ramped up, and are readily expressed as 
functions of either time or temperature in the case of a linear heating ramp (the 
relationship T = T0 + mt applies, where m is the rate of increase of the reactor 
temperature). The value of kcat is given by Equation 3-1, and the value of [N] is derived 
by combining the definitions of Keq and Kmg, the mass balance on species N, M, U, and 
D, and the first-order denaturation rate law which states d[D]/dt = kinact[U]. 
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 Upon rearrangement, and application of the chain rule, Equation 3-9 is 
transformed into a first-order differential equation for which K1 = d(Keq)/dt and K2 = 
d(Kmg)/dt. The rate of disappearance of native enzyme at any time (or temperature) 


























3.1.3  Functional Comparison of Methods/Models 
 Unlike the three-state, isothermal Equilibrium Model in which all of the 
equilibrium constants and the deactivation rate constant are constant through the course 
of an experimental run, this four-state, non-isothermal model equation is not readily 
integrated analytically. However, provided that the continuous temperature ramp 
experiment is started at any temperature well below the Tm of the enzyme, such that Kmg 
<< Keq, Equation 3-10 may be solved numerically by assuming an initial value of 
[N]0 = E0 / (1+Keq). Essentially, the continuous ramp method uses variable Keq, kcat, and 
kinact, whereas the Equilibrium Model (in isothermal batch-mode) allows these all to be 
held constant. Both methods, however, assume the intrinsic activation and deactivation 
parameters (ΔGcat, ΔGinact, ΔHeq, Teq) remain nearly constant over the entire temperature 
range of interest. 
 In this work, we have studied the thermal deactivation of TEM-1 β-lactamase 
from Escherichia coli, using both the isothermal batch techniques and the continuous 
EMR temperature ramp, on the same batch of enzyme, to assess the relative strengths of 
the two methods. Previously, a Class C metallo-β-lactamase from Bacillus cereus had 
been studied using the batch-mode method with the Equilibrium Model, but a Class A β-




3.2  Experimental Section 
3.2.1  Materials 
 The TEM-1 β-lactamase (E.C. 3.5.2.6) was over-expressed in Escherichia coli 
and purified from the expression medium via ammonium sulfate precipitation and ion 
exchange chromatography as in Section 2.3.3. Penicillin G potassium salt was purchased 
from USB Corp. (Cleveland, OH). Coomassie Protein Assay Reagent was obtained from 
Thermo Scientific (Rockford, IL). All other chemicals used were of analytical grade. 
3.2.2  Batch-mode Experimental Setup 
 Enzyme activity was measured according to the spectrophotometric penicillin G 
assay described in Subsection 2.3.4.2., using a Thermospectronic Helios γ-
spectrophotometer equipped with a Thermospectronic single-cell Peltier-effect cuvette 
holder. This system was networked to a computer installed with Vision32 (Version 1.25, 
Unicam) software for recording absorbance vs. time data. A quartz cuvette with a 0.5 cm 
path length was used during the course of all experiments, due to the favorable optical 
and heat transfer properties. The cuvette was kept isothermal during the course of each 
experimental run and a Cole-Parmer Digi-Sense thermocouple thermometer was used to 
ensure there was no temperature gradient larger than 0.1°C within the cuvette, or from the 
beginning to the end of the run. Runs were discarded and repeated if a temperature 
gradient was detected. The thermometer and the temperature control bath were calibrated 
using a Cole-Parmer NIST-traceable glass thermometer. 
 For each run, 1.0 mL of substrate solution was added to the cuvette, along with a 
2 mm diameter Teflon-coated stir wire, and the system was allowed to thermally 
equilibrate for a minimum of 5 min. A stock solution of enzyme, with concentration 
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determined by Bradford assay (measurement of A280 in the presence of Coomassie 
Protein Assay Reagent), was used to prepare a sample with a final concentration of 32 
μg/mL. After thermal equilibration, 5 μL of the enzyme solution (for a total enzyme 
concentration of 5.5 nM) was injected directly into the cuvette using a positive 
displacement pipettor and the contents of the cuvette were agitated rapidly for 3 seconds 
using the preheated stir wire. After stirring was completed, the software began recording 
absorbance data. 
 The combination of substrate concentration, cuvette path length, and enzyme 
loading was chosen such that the starting absorbance never exceeded 1.5 AU (to preclude 
instrument saturation), and the substrate conversion never exceeded approximately 40% 
at any of the temperatures examined. Hence, the substrate concentration was never lower 
than about 2.6 mM; a value over 100 times the published KM value of the enzyme for 
penicillin G at 25°C.14 Reactions were allowed to proceed for 120 s, with data points 
acquired at two-second intervals. 
 Triplicate assays were performed at each temperature, and the absorbance vs. time 
data were converted to reaction rate vs. time data. The average of the three rates at each 
time point was used to construct a single progress curve of reaction rate vs. elapsed assay 
time for each given temperature. The progress curves were smoothed using a Loess 
transformation (SigmaPlot® 2001 for Windows) to eliminate noise from the data, and the 
smoothed curves for all temperatures were initially fitted to the Equilibrium Model using 
MATLAB®, with initial parameter estimates of ΔGcat = 85 kJ/mol, ΔGinact = 100 kJ/mol, 
ΔHeq = 120 kJ/mol, Teq = 320 K. The resulting fitting parameters resulting from the first 
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run were used as improved initial estimates for a second run, which then provided the 
final parameter values.9 
3.2.3  Continuous-mode EMR Experimental Setup 
 Substrate conversion vs. time data were collected in an EMR which was 
configured to operate as a CSTR. A single sample of enzyme was charged to a reactor 
with a working volume of 10.0 mL and a solution of 200 mM sodium phosphate buffer 
and 20 mM penicillin G (pH 7.0) was continuously fed to the reactor at a rate of 1.25 
mL/min. The buffer system was selected and tested to ensure that the pH remained at 
6.8–7.0 over the entire experimental temperature range and all levels of substrate 
conversion. The penicillin G feed solution was kept refrigerated at 4°C during 
experiments to preclude thermal degradation. To counteract the effects of β-lactamase 
absorption to the membrane surface, a loading of 1.0 mg/mL bovine serum albumin 
(BSA), which exhibited no activity toward the substrate, was charged to the reactor at 
least one hour prior to each injection of β-lactamase. Control runs were performed at 4°C, 
in the absence of thermal enzyme deactivation, to rule out the effects of membrane 
absorption and shear stress damage to the enzyme due to stirring. Zero activity loss was 
detected after 36 h of reactor operation during the control runs. 
 After a one-hour equilibration period at the initial temperature of 295 K, the 
reactor temperature was progressively increased to 330 K using a linear temperature ramp 
of 2 K/h. The substrate conversion was monitored by measuring the optical rotation of 
the reactor effluent stream via an in-line polarimeter with a sample cell which was kept at 
25°C by external water bath. At 25°C, the specific optical rotation of the substrate 
mixture was α589 = 1078 M-1 while that of the product was α589 = 578 M-1. To account for 
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background thermal degradation of the substrate, a calibration curve was constructed by 
first running pure unreacted feed and then completely hydrolyzed product through the 
entire temperature ramp (see Subsection 2.3.4.3 for full details). 
 The conversion vs. time data were smoothed with the MATLAB® Curve Fitting 
ToolboxTM, using a Robust Loess method with span = 85. The smoothed experimental 
data were fitted according to Equations 3-6 and 3-10, using an iterative solving procedure 
to minimize the sum of squared residuals by adjusting the fitting parameters (see 
Appendix B). Two different numerical techniques were used to solve the initial value 
problem (IVP) of Equation 3-10: an implicit Euler method with a time interval of Δt = 
120 s and an area-under-the-curve approximation according to the trapezoidal rule, with a 
time interval of Δt = 120 s. In addition, a model was generated which omitted the folding 
state, U, and assumed only a three-state model equivalent to the Equilibrium Model. An 
attempt was then made to fit the continuous EMR data to this three-state model for 
purposes of comparison, using the area-under-the-curve approximation per the 
trapezoidal rule for the numerical integration. 
 
3.3  Results and Discussion 
3.3.1  Batch-mode Results 
 A total of ten progress curves for the enzyme were measured, each in triplicate, 
over the temperature range from 292 K to 332 K. The temperature spacing between 
progress curves was varied through the course of the experiments, and two of the 
progress curves were measured at high temperatures, such that the initial reaction rate had 
fallen below its peak value (i.e. the temperature was above Topt). The experimental data 
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for rate vs. temperature vs. time, overlaid with the rate predicted by the MATLAB® 
routine according to Equation 3-4, is shown in Figure 3.3. 
 
 
Figure 3.3  Isothermal batch-mode results. Experimental data shown in red, fit to the 
Equilibrium Model shown in blue (the model is the higher surface at the “peak”)  
 
3.3.2  Continuous-mode EMR Results 
 Figure 3.4 depicts the experimental data from the continuous EMR temperature 
ramp experiment, overlaid with three different model predictions: the four-state molten 
globule model using the implicit Euler technique, the four-state molten globule model 
using the trapezoidal rule, and the three-state Equilibrium Model. The values of the 
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deactivation parameters which were found by the various experimental methods and 
model fitting procedures are shown in Table 3.1. 
 
 
Figure 3.4  Continuous temperature ramp results. 
 
3.3.3  Comparison of Models to Experimental Data 
 Figures 3.3 and 3.4 show the experimental data for the batch mode and 
continuous methods, respectively, overlaid with the predictions of the models. One 
conspicuous feature of the experimental data for both the isothermal batch and 
temperature ramp methods is that the early (low-temperature) segment of the curve shows 
a near-linear increase of activity with temperature. In the absence of any deactivation 
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effects in this regime, one would expect the curve to be concave upward, more closely 
resembling an Arrhenius-type activation profile. The near-linear increase in the 
isothermal batch-mode data suggests the onset of activity loss at a temperature well 
below the traditional Tm of TEM-1 β-lactamase, which is 51.5°C as evidenced by 
interpretation of the circular dichroism spectrum.15 It is clear that a different effect must 
be responsible for the activity loss in the vicinity of 310–315 K, more than 10°C below 
the Tm, contrary to the widely held belief that the optimum operating temperature of a 
biocatalyst is very close (within a degree or two) to its melting temperature, but is 
expected for an enzyme following the Equilibrium Model.10,16 This may only hold true 
for those enzymes for which global secondary structure and active site integrity are 
compromised simultaneously. 
 
Table 3.1  Estimation of deactivation parameters. Isothermal batch-mode tests and 
continuous temperature ramp EMR methods (standard deviations for batch isothermal 
data are shown in parentheses). 
 
















(0.3) - - 
92.1 
(0.2) - 
EMR (four-state, Euler) 54.0 64.6 317.9 716.5 328.6 101.2 0.1835 
EMR (four-state, trapezoidal) 54.2 74.9 309.2 699.7 324.7 100.6 0.0497 
EMR (three-state, trapezoidal) 54.8 69.4 330.5 - - 101.0 1.7198 
 
 
 The three-state deactivation model resulted in a relatively poor fit to the 
continuous non-isothermal data from the EMR. Similar to the fit of the Equilibrium 
Model to the batch results in Figure 3.3, the three-state deactivation model, numerically 
integrated by the trapezoidal rule, tends to underestimate the enzyme activity on the low-
temperature end of the EMR experiment, anticipating an Arrhenius-type increase as 
temperature rises. It can be clearly seen that the predicted slope of the rate vs. 
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temperature trend, in the low-temperature regime, is significantly greater than that of the 
experimental data, for both the three-state batch and three-state temperature ramp models. 
 Notably, however, the three-state isothermal Equilibrium Model (MATLAB® 
routine) resulted in a relatively good fit to the batch data in the high temperature regime, 
particularly near the Teq of 314 K, whereas the three-state EMR model was unable to 
converge upon a good fit in this regime. One explanation for this inequality could be the 
large difference in time scales between the two experimental methods. At temperatures a 
few degrees below the Teq, denaturation during the course of the experimental run may be 
nearly invisible in the two-minute isothermal batch assay. The three-state EMR model, 
however, is forced to include the cumulative effects of denaturation over a much longer 
time, as the time between each data point in the EMR model is 120 s, the same length as 
the entire progress curve of the batch model. 
 Thus, at a moderate temperature, which is apparently “nondenaturing” as seen in 
the shorter batch assay, a significant amount of time has passed in the continuous EMR 
run and there is already much less active enzyme present than if the enzyme was exposed 
to that temperature for the first time. Indeed, it has been previously shown in the 
literature that insufficient monitoring time, particularly at higher temperatures, can 
disguise the equilibrium character of inactivation and thus make it difficult to fit data to a 
model which would remain consistent in longer assays.17 Effects such as uncooperative 
unfolding and grace-period inactivation can influence the accuracy of such short-term 
assays. The effects of varying the temperature ramp rate in the continuous EMR are 
explored in further detail in Chapter 5. 
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3.3.4  Physical Significance of Parameters 
 There is ample evidence in the literature that several β-lactamases follow a four-
state unfolding mechanism.18–20 It has been previously established by use of guanidinium 
chloride denaturation experiments that TEM-1 β-lactamase does not follow a simple 
“one-step, two-state” folding mechanism, but rather exhibits a thermodynamically stable 
intermediate state in equilibrium with the native and unfolded states, likely influenced by 
the cis/trans isomerization of Xaa-Pro peptide bonds.21 This intermediate state, described 
in the literature, is modeled here to correspond to the molten globule state of the four-
state model. 
 The batch-mode isothermal Equilibrium Model and the non-isothermal four-state 
temperature ramp models, remarkably, were in good agreement with respect to the 
location of the Teq, though the batch-mode Equilibrium Model predicted a higher ΔHeq, 
which may be because the three-state model is converging on an intermediate value 
somewhere between the enthalpy change necessary to enact a conformational change at 
the active site (ΔHeq of the four-state model), and the enthalpy change associated with the 
onset of unfolding (ΔHmg of the four-state model). The four-state model makes a 
distinction between these two transitions, in which the molten globule state M exhibits no 
activity but also does not readily become permanently denatured, whereas the unfolded 
state is much more readily denatured, an effect which corresponds to the sudden loss of 
activity in the vicinity of Tmg. In addition, the nature of the Equilibrium Model equation 
is such that ΔHeq is subject to relatively high errors.6,9 Discrepancies between the two 
models may be due to the fact that the Equilibrium Model treats the Einact to X transition 
as a single event, although not necessarily via a single product.7 Alternatively, it may be 
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due to the fact that, for this enzyme, data for the Equilibrium Model has only been 
collected for two minutes. The value of Tmg predicted by the temperature ramp four-state 
trapezoidal model (the better fit of the two four-state models) is 51.7°C, which coincides 
almost exactly with the documented Tm of the enzyme, as measured by circular 
dichroism.15 
 The values for ΔGinact predicted by the four-state continuous model were 
somewhat higher than those from the three-state batch-mode Equilibrium Model. Again, 
this may be attributable to the fact that there is a very large timescale difference between 
the two experiments, and the prediction of the first-order denaturation rate constant kinact 
may appear to be quite different during a two-minute assay than over the course of 
several hours. 
 The ΔGcat value of 54.2 kJ/mol predicted by the continuous four-state trapezoidal 
model gives a turnover number of 1530 s-1 at 25°C, which is in excellent agreement with 
the literature value of 1500 s-1 for TEM-1 using penicillin G as a substrate.22 The 
predicted ΔGcat was slightly lower in the three-state batch-mode Equilibrium Model, at 
53.6 kJ/mol, corresponding to a turnover number of 2550 s-1 at 25°C. The discrepancy 
between these two values could be a consequence of experimental error associated with 
the Bradford assay in determining the initial enzyme concentration, or it may be due to 
determinations of kcat having been made under conditions for which not all of the enzyme 
is active.7,23 However, the difference is not far from the sum of the fitting and 
experimental errors expected for the determination of Equilibrium Model parameters.9 
 The four-state continuous temperature ramp models predict the ΔHmg to be nearly 
an order of magnitude higher than the ΔHeq value, which is in agreement with the notion 
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that the conformational shift needed to render the enzyme inactive is slight compared to 
the complete unfolding of the enzyme.7,8,24,25 The value of 700 kJ/mol for the enthalpy 
change upon unfolding is in the typical range for globular proteins such as β-lactamase I 
from Bacillus cereus, which exhibits a denaturation enthalpy of 646 kJ/mol, although this 
is low compared with subtilisin.26 
 The two numerical integration methods used with the four-state model (implicit 
Euler method and trapezoidal rule) predicted nearly the same values for ΔGcat, ΔHmg, and 
ΔGinact. The two methods produced slightly different predictions for the Tmg, which may 
be due to the different behavior of the two integration techniques in the vicinity of Tmg. 
The trapezoidal rule method, which resulted in a better overall fit, was particularly more 
effective than the implicit Euler method at tracking the experimental data in this regime 
where the rate of change of conversion with respect to time is high. The significant 
difference between the two models was in their predictions of ΔHeq and Teq. The implicit 
Euler method showed a higher Teq with a lower energy barrier, while the trapezoidal 
method showed the converse arrangement. Nevertheless, both methods confirmed that 
ΔHeq was about an order of magnitude less than the ΔHmg indicated by both the four-state 
continuous experiment and CD data from literature and that the Teq was at least 10°C 
lower than Tmg (i.e. melting temperature Tm). 
 
3.4  Conclusions 
 Though the three-state Equilibrium Model (Figure 3.1) did not result in a good fit 
to the data obtained by the continuous temperature ramp method, it resulted in a 
relatively good fit to the isothermally obtained batch data, although the predicted value of 
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ΔGcat was slightly low and the abbreviated increase of actual reaction rate with 
temperature was not fully captured by the model. The four-state deactivation model 
(Figure 3.2), especially when the steep changes around Tmg were tracked by a routine 
employing the trapezoidal rule rather than Euler’s method, resulted in an excellent fit to 
the data collected by the continuous temperature ramp EMR experiment, and furthermore 
showed good agreement with the batch-mode Equilibrium Model regarding the location 
of Teq, the temperature of transition between native, active enzyme and conformationally 
compromised, inactive enzyme. 
 Whereas the four-state model contains a higher number of fitting parameters and 
should admittedly result in an improved fit over the three-state model, there is, as 
discussed earlier, copious evidence in the literature which indicates TEM-1 β-lactamase 
unfolds via a four-state mechanism. Both the three-state Equilibrium Model and four-
state continuous model were effective at pinpointing the transition between active and 
inactive enzyme. The finding of two distinct transitions in the temperature ramp EMR 
model corroborates the previously established notion that Teq is separate from Topt, with 
the latter depending on a mix of Teq, ΔGcat, and ΔHeq.5–7 Both are important to protein 
engineers who wish to characterize and design biocatalysts. It is clear that the difference 
in timescale of these two experimental modes may affect the parameters predicted by 
model fitting. Denaturing effects which may be ignored during an assay lasting only a 
few minutes will have a greater effect on models which seek to capture the cumulative 
deactivation over several hours. A low degree of cooperativity in the process of 
transitioning between native and denatured states is likely one source of discrepancy 
between the two experimental methods. 
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 The discontinuous Equilibrium Model batch method has a string of advantages. 
The collection of an array of isothermal progress curves, while labor-intensive compared 
to the continuous temperature ramp experiment, can be fitted to a model which is 
mathematically straightforward in that all temperature-dependent equilibrium constants 
remain unchanged during progress curves. The batch method also uses smaller quantities 
of substrates, buffers, and other reagents and can be performed with commonplace 
instrumentation and equipment, so there is no need to configure a CSTR. In the current 
study with TEM-1 β-lactamase, the Equilibrium Model was equally as capable as the 
more complex four-state continuous model in identifying the Teq of the enzyme. So far, 
all enzymes for which Equilibrium Model data has been collected obey the model.7,8 
 The temperature ramp method, although it is faster and requires minimal direct 
monitoring, and furthermore utilizes a single injection of enzyme (minimizing systematic 
error), requires a model which relies on numerical integration techniques due to the 
complicated behavior of native enzyme population when temperature increases with time. 
However, the ability of the continuous EMR system, in conjunction with the four-state 
deactivation model, appears to be a powerful tool for examining multiple thermodynamic 
transitions (N to M as well as M to U), both of which are of great importance in 
biocatalyst design, in a single experiment. This technique can likely be extended to other 
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UTILIZING SIMPLE BIOCHEMICAL MEASUREMENTS TO 
PREDICT LIFETIME OUTPUT OF BIOCATALYSTS IN 
CONTINUOUS ISOTHERMAL PROCESSES  
 
4.1  Introduction 
 The expected product yield of a biocatalyst during its useful lifetime is an 
important consideration when designing a continuous biocatalytic process. One important 
indicator of lifetime biocatalyst productivity is the dimensionless total turnover number 
(TTN). The TTN represents the total number of catalytic events performed by a single 
enzyme molecule during its lifetime (i.e. before it is permanently deactivated) or, 
alternatively, the number of moles of product which will be yielded by one mole of 
biocatalyst under the specified process conditions.  Here, a method is proposed for 
estimating the TTN of a given biocatalyst from readily measured biochemical quantities, 
namely the specific activity and the deactivation half-life, measured under identical 
conditions. We demonstrate that this method may be applied to any enzyme whose 
thermal deactivation follows first-order kinetics, regardless of the number of unfolding 
intermediates, and that the TTN method circumvents the potential problems associated 
with measuring specific catalyst output when a portion of the enzyme is already unfolded. 
The TTN estimation was applied to several representative biocatalysts to demonstrate its 
applicability in identifying the most cost-effective catalyst from a pool of engineered 
mutants with similar activity and thermal stability. 
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4.1.1  Stability Considerations for Industrial Biocatalysts 
Biocatalysts are often superior to conventional catalysts in terms of high 
specificity, enantioselectivity, and catalytic efficiency.1-3 In addition, enzyme catalysts 
possess many environmentally attractive attributes such as their biodegradability and 
propensity to operate at moderate temperature and pH in aqueous systems.4-6 As such, 
biocatalysts are of great interest, particularly in the pharmaceutical and specialty 
chemicals industries where enzymes can often provide the needed level of product purity 
in relatively few process steps. Despite all of these advantages, the use of biocatalysts 
remains somewhat limited on the industrial scale.7-8 In large part, this is due to the fact 
that enzymes, derived from biological sources, have evolved to function most efficiently 
in conditions resembling those found in biological systems.  When taken out of their 
highly-evolved biological niche and placed under the conditions of a foreign commercial 
chemical process, many enzymes suffer in terms of long-term stability. There are, of 
course, exceptions to this rule and researchers are increasingly able to impart stability to 
biocatalysts by learning from the amino acid sequences of enzymes which tolerate harsh 
conditions, or by adding compounds to the reaction mixture.9-11 Enzymes can be tailored 
to resist organic solvents as well as salts,12 but thermal stability is an especially important 
trait since elevated temperature leads to more favorable reaction kinetics in a wide variety 
of processes.13 
The choice of operating temperature in an enzyme-catalyzed process involves the 
consideration of two competing processes: the rise in catalytic activity with increased 
temperature according to the well-known Arrhenius rate law, and the loss of structural 
integrity at the enzyme’s active site due to thermally induced conformational changes 
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and/or protein unfolding.14,15 Operating a process at a temperature very near the melting 
temperature (Tm) of an enzyme generally results in maximal turnover number but also in 
rapid deactivation. Since the cost of the biocatalyst itself is often significant, along with 
the potential down-time required to frequently replace spent catalyst, this may be an 
unfavorable operating regime. On the other hand, operating at temperatures far below Tm 
may prolong the catalyst lifetime and reduce energy costs but could result in 
unreasonably low space-time yields. As demonstrated in the literature, the true optimum 
temperature for an enzyme may be well below that at which denaturation becomes 
apparent through short-term experiments.16,17 
4.1.2  Total Turnover Number as a Productivity Indicator 
In many cases, the range of acceptable operating temperature may be dictated by 
process constraints and the biocatalyst must be engineered to operate within that range. 
The protein engineer may be confronted with a large library containing several variants 
with similar activity and stability at the desired temperature, and must decide which 
variant will be most cost-effective over its process lifetime. While traditional indicators 
of biocatalyst performance based on intrinsic enzyme properties such as the Vmax/KM 
ratio are often utilized, these overlook the features of the specific process. Therefore, an 
indicator such as the catalytic effectiveness, which incorporates the enzyme behavior 
over the entire course of the reaction, is likely more applicable.18 However, the TTN is an 
even more meaningful indicator of the suitability of a biocatalyst in a given process, as it 
directly scales the product yield to the catalyst input which renders it especially useful in 
cost estimation. 
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In a continuous process using soluble, polymer-bound transfer hydrogenation 
catalysts (‘‘chemzymes’’), the TTN has been estimated to be the quotient of the catalyst 
turnover number and the rate constant of spent catalyst replacement.19 The notion of 
scaling activity to catalyst loss, i.e. deactivation rate, to estimate TTN has been developed 
for enzymatic systems by incorporating protein stability models such as the Lumry–
Eyring model.3 However, enzymes can lose catalytic activity before they undergo a 
global loss of secondary structure, i.e. unfolding, and as such the deactivation process 
may involve multiple stable intermediate states.20 Thus, the question of catalyst activity 
loss is relatively complicated in the case of enzymes and can depend on several 
thermodynamic equilibrium processes. 
Here, it is demonstrated that the TTN of a biocatalyst in a continuous, isothermal 
process can be estimated by performing two simple biochemical measurements. These 
measurements, the observed catalytic constant (kcat,obs) and the observed deactivation rate 
constant (kD,obs), take into account the operating conditions of the actual process and do 
not require a detailed knowledge of the enzyme’s deactivation mechanism. Assuming 
only that thermal deactivation of all active and intermediate forms of the enzyme 
proceeds via first-order kinetics, it is shown that regardless of the number of steps in the 
unfolding process, the TTN is simply the quotient kcat,obs/kD,obs when both values are 
measured at the chosen process temperature. These data are readily measured with 
common laboratory instrumentation and eliminate the potential problem of errant activity 
readings which ignore the fact that all of the enzyme in the initial sample may not be in 
its native (active) state. 
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4.2  Methods 
4.2.1  Observed Enzyme Activity in an Isothermal Process 
An enzyme will only exhibit catalytic activity when its native conformation is 
preserved.  The maximum catalytic output is achieved when the enzyme is continuously 
kept saturated with substrate during its lifetime, i.e. when operating conditions are such 
that substrate concentration >> KM  of enzyme at all times.   Under saturated conditions, 
the instantaneous reaction rate Vmax is given by Equation 4-1, where [N] is the 
concentration of native (active) enzyme present. 
 
max [ ]catV k N=   [4-1] 
The specific turnover number of the enzyme, kcat, is a function of temperature 
which can be defined according to thermodynamic transition state theory, as seen in 
Equation 4-2, where kB = Boltzmann constant, h = Planck’s constant, and R = gas 
constant.  In an isothermal process, the value of kcat remains constant and depends only 
on the intrinsic activation parameter ΔGcat, the change in Gibbs free energy associated 
with activation of the enzyme-catalyzed reaction.  Thus, for a given enzyme in an 
isothermal process, the observed Vmax depends only on one quantity which is variable 
with respect to time:  the concentration of enzyme [N] which is still in its native state.  
Furthermore, the expression for the observed reaction rate may be written with time as 
the only variable, as shown in Equation 4-3, where kcat is taken to remain constant for the 
duration of the isothermal process.  Therefore, to calculate product yield over the course 











max ( ) [ ]( )catV t k N t=   [4-3] 
 
4.2.2  Generalizable Model for Long-term Enzyme Deactivation 
Upon exposure to a denaturing condition such as a chemical denaturant or heat, an 
enzyme loses its native conformation and is rendered inactive, at least temporarily.  
Removal from the denaturing condition can result in the partial recovery of catalytic 
activity, but if the inactivated enzyme is held under the denaturing condition for a 
sufficiently long time it will become permanently and irreversibly denatured.21 The well-
known Lumry-Eyring model of protein stability, shown in Figure 4.1, treats enzyme 
denaturation as a two-step process:  first, equilibrium between the native and unfolded 
conformations of the enzyme, designated N and U, respectively (the equilibrium constant 
K = [U]/[N]), and second, a first-order permanent denaturation (with rate constant kD) of 
the unfolded enzyme to a final state D.22 More recent deactivation models, such as the 
Equilibrium Model recognize that, in general, any conformational change which 
compromises the integrity of the active site of the enzyme will cause catalytic activity to 
cease, whether or not this conformational change corresponds to the unfolding of the 
enzyme, i.e. loss of secondary structure.15,17  In such a case, an equilibrium is assumed 
between the native and inactive (though not necessarily unfolded) states.  Figure  4.2 
shows the Equilibrium Model, in which Eact represents enzyme in its native 
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Figure 4.1.  Lumry-Eyring model. 
 
 
Figure 4.2.  Equilibrium Model with associated constants. (Daniel et al., 2001)23 
 
Both the Equilibrium Model, which in practice is often applied to short-term 
enzyme deactivation data with assays on the order of several minutes15,23 and the Lumry-
Eyring model assume that an enzyme must reach the unfolded or inactive state before it 
may become permanently denatured.  When modeling enzyme deactivation over 
relatively long time periods, it may be necessary to consider other denaturing events 
which are not preceded by equilibrium unfolding, otherwise the models may result in 
artificially high total turnover predictions by ignoring effects which are best observed 
during assays longer than a few minutes.  Gibbs et al. (2005) have previously suggested 
an “Extended Lumry-Eyring” model which includes a direct path for first-order 
denaturation from the native state, as seen in Figure 4.3. 
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Figure 4.3.  Extended Lumry-Eyring model.  (Gibbs et al., 2005)3 
 
Another feature common to the models in Figures 4.1-4.3 is that they model only 
one intermediate state between the native and permanently denatured states.  Even though 
none of these models explicitly preclude the existence of additional unfolding 
intermediates, none are able to make a distinction between stable intermediates which 
have attained different degrees of unfolding.  The existence of multiple unfolding 
equilibria would result in a deactivation model such as the one shown in Figure 4.4, in 




Figure 4.4.  Multiple-intermediate model. (Freire et al., 1990)24 
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By combining the elements of the schemes in Figure 4.3 and 4.4, a generalizable 
theoretical model is proposed here which not only allows for multiple stable unfolding 
intermediates but also recognizes that each of these intermediates may proceed directly to 
a permanently denatured state, as shown in Figure 4.5.  For clarification, the use of a 
single state D in Figure 4.5 is not an attempt to assert that all permanently denatured 
conformations which may be attained are identical, merely that they are all irreversible 
and nondescript, i.e. no longer considered to be species which participate in equilibria. 
 
 
Figure 4.5.  Multiple intermediate model with direct denaturation pathways 
 
4.2.3  Progress of Enzyme Deactivation During an Isothermal Process 
By adopting the general deactivation model in Figure 4.5, an expression can be 
derived for the amount of native enzyme remaining at any time during an isothermal 
process, i.e. the [N](t) term needed to complete Equation 4-3.  The complete derivation of 
this term from the mass balance on all enzyme species and the thermodynamic definitions 
of the equilibrium constants and rate constants is shown in Appendix A.  The result in 

















































In an isothermal deactivation experiment, the “observed” or apparent deactivation 
rate constant (kD,obs) resulting from the combination of all deactivation pathways will be 
equivalent to the exponential term of Equation 4-4, which may then be written more 
concisely as Equation 4-5.  Substitution of this result into Equation 4-3 gives the desired 



















































The entire pre-exponential of Equation 4-6, except for [E]0, is equivalent to the 
“observed” or apparent kcat in an isothermal experiment.  Assuming that all 
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thermodynamic equilibria between the native state and the n intermediate states are 
established very rapidly, the kcat observed by instrumentation will be necessarily lower 
than the intrinsic kcat since some of the enzyme sample has already been rendered 
inactive and the activity calculation must be corrected by this factor.  Hence, the final 
expression for instantaneous reaction rate as a function of time is given in Equation 4-7. 
 
,
max , 0( ) [ ] D obs
k t





4.3  Results and Discussion 
4.3.1  Total Turnover Number Expression from Stability Model 
The process yield during the lifetime of a biocatalyst is equivalent to the integral 
of the instantaneous rate (Vmax) with respect to time, from zero to infinity (Equation 4-8).  
The expression for yield is obtained directly from the result of Equation 4-8, in which the 
non-varying terms kcat and [E]0 may be taken outside the integral (Equation 4-9).  The 
integrated solution for overall yield is shown in Equation 4-10.  The solution is then 
transformed to the dimensionless TTN after dividing by the concentration of biocatalyst 
initially present (specific yield per mole of catalyst).  The final expression for TTN is 




( )yield V t dt
∞
= ∫   [4-8] 
 




























,=                                          [4-11] 
 
4.3.2  Estimation of TTN from Activity and Deactivation Data 
To obtain an idea about the order of magnitude of TTN for stable biocatalysts, the 
result of Equation 4-11 was applied to an assortment of different biocatalysts which 
exhibit first-order deactivation behavior, and for which both activity and deactivation 
data were available at the same temperature and buffer/substrate system.  The first 
requirement for the application of this method is a first-order deactivation rate constant at 
the desired process temperature.  Frequently, published first-order deactivation data are 
expressed in terms of a half-life, from which the rate constant can easily be extracted.  
The second requirement is the apparent turnover number (kcat,obs) measured at the same 
temperature as the deactivation data.  In cases where the apparent value of kcat is not 
given explicitly in the literature, it can be calculated from the more prevalent specific 
activity data (U/mg) provided that the molecular weight of the enzyme per active site, or 
alternatively the overall molecular weight and number of active sites per enzyme 
molecule, is known.  Equations 4-12 and 4-13 give the conversion formulas to derive 
kcat,obs from specific activity (U/mg) and kD,obs from half-life (converted to seconds). 
 










−                                 [4-13] 
 
Half-life and specific activity are indeed two of the most important parameters 
which characterize the thermal stability of an enzyme, and are thus available for a wide 
variety of biocatalysts; however, it is important to stress that the data must be obtained 
under the same conditions of temperature, pH value, and buffer content.  Table 4.1 shows 
estimates of TTN for several biocatalysts which have been calculated according to 
Equation 4-11. 
The TTN, which itself is a dimensionless quantity, in each case corresponds to the 
expected yield in moles of product per mole of catalyst over the enzyme’s lifetime.  Not 
surprisingly, the β-glucosidase and the glucose dehydrogenase from Sulfolobus 
solfataricus, which are industrial-grade catalysts derived from thermophilic organisms for 
their high thermal stability, exhibit relatively high TTN (on the order of 1-10 million).  
The data for subtilisin S41 illustrate how the engineered improvements to activity and 
stability translate into overall productivity; between the wild-type S41 and the improved 
variant 3-2G7 the specific activity was improved by a factor of 2.1 and the half-life 
increased by a factor of 59.  Per the TTN estimation, the improved biocatalyst can be 
expected to yield approximately 127 times more product than the S41 over its lifetime.   
The utility of Equation 4-11 in selecting the best candidate catalyst for a given 
process from a pool of similar mutants can be seen in the data for cephalosporin acylase.  
Compared to the CA130 wild-type, the R121βA mutant has nearly the same specific 
activity but a longer half-life, and as expected exhibits a higher TTN.  The D286βA 
mutant, compared to wild-type, shows a very slight (3%) increase in activity but a 21%  
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Table 4.1.  TTN estimates for several representative biocatalysts. 
 










hexenone 45 4.5 1.95 9.87 x 10




[1] 100 10.8 85 2.26 x 10
-6 4.77 x 106 28 
glucose dehydrogenase 
(Sulfolobus solfataricus) D-glucose 70 74.9 45 4.28 x 10
-6 1.75 x 107 26,27 
subtilisin S41 
(Antarctic Bacillus TA41) s-AAPF-
pNa[2] 
60 264 0.16 1.24 x 10-3 2.13 x 105 
29 
subtilisin 3-2G7 
(Antarctic Bacillus TA41) 60 553 9.43 2.04 x 10



















37 12.7 53.9 3.57x 10-6 3.56 x 106 
glucose dehydrogenase 
strain 168 wild-type 
(Bacillus subtilis) 
D-glucose 













25 33.1 0.67 2.89 x 10-4 1.15 x 105 
[1]:  p-nitrophenyl-b-D-glucopyranoside 
[2]:  succinyl-LAla-LAla-LPro-LPhe-p-nitroanilide 






shorter half-life, and accordingly can be expected to have an 18% lower TTN.  The 
K198βA mutant, though it has 5% lower activity than the wild-type, has a 58% longer 
half-life.  This translates into a 50% higher TTN and thus makes it the most productive 
variant for the given substrate at a process temperature of 37°C.A similar pattern is seen 
in the data for the glucose dehydrogenase strain 168, from Bacillus subtilis, and its 
mutants.  The A246V mutant illustrates that in some cases one property (activity) may be 
increased at the expense of another (half-life) and result in an improved TTN, while the 
P105S mutant shows that this will not always be the case.  The V227A mutant, though 
19% less active than the wild-type, has an 80% longer half-life; the combination 
translates into a TTN which is 49% higher than that of the wild-type. 
4.3.3  Strengths and Limitations of the TTN Method 
The TTN captures the amount of product synthesized per amount of enzyme 
expended.  As such, and with the assumption that prices for both product and biocatalyst 
are known, the contribution of the biocatalyst to the overall variable costs of production 
can easily be determined.  At that point already, such a determination results in one of 
three situations:  i) the cost contribution of the biocatalyst is negligible (no further work 
required), ii) the cost contribution of the biocatalyst is overwhelming, maybe more than 
the price of the product (different biocatalyst or process is required), or iii) the cost 
contribution is neither negligible nor overwhelming, i.e. acceptable but can often be 
improved.  The method allows straightforward comparison between different 
biocatalysts.  As such, TTN is one of the most important criteria for process development. 
The TTN estimation should not be employed as the sole criterion for process 
suitability because biocatalysts can exhibit very large TTN at temperatures well below 
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their optimum operating range.  One study concluded that TTN of a given enzyme 
continues to increase as temperature is decreased due to the extended lifetime of the 
enzyme - however these yields could not be achieved in a practical sense, i.e. without 
unreasonably long residence times.3 Therefore, the TTN should also not be used as a tool 
for deciding the best operating temperature for the enzyme, as this will invariably be the 
lowest available temperature.  Rather, the TTN method is highly applicable when an 
approximate design temperature is already known and several catalysts must be 
compared to decide which one is the best performer at that temperature. 
Another limitation of the TTN method is the assumption that all deactivation 
pathways obey first-order kinetics.  In real processes, many effects such as protein 
aggregation may lead to loss of catalytic activity, and these may not always follow first-
order rate laws.  The inclusion of kcat,obs as a parameter also introduces some potential for 
inaccuracy.  At higher operating temperatures where denaturation is relatively rapid, it 
may become increasingly difficult to capture the true initial enzyme activity in a 
conventional assay.  A trade-off may occur in which the assay must be short enough in 
duration to exclude the time-dependent effects of denaturation but long enough to capture 
enough data points for a good fit and an acceptable signal-to-noise ratio from the 
instrumentation.  It should also be noted that the isothermal experiments to determine 
kd,obs in cases where no literature exists, though very simple in design, may still need to 
span days or weeks especially in the case of industrially useful enzymes.  An accelerated 
non-isothermal method for determining the TTN may be preferable in such cases.3 
 The primary advantage of the TTN method is that it uses two quantities which are 
easily observed with common laboratory instrumentation, if not already available in the 
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literature.  Both the kcat,obs and kD,obs are easily extracted from specific activity and half-
life data, respectively, which are widely published for a large number of biocatalysts.  
Another advantage of this method over some others which track the enzyme behavior 
through the course of an entire scaled-down reaction is that here the necessary parameters 
may be measured in discontinuous batch experiments, which involves less experimental 
labor, smaller quantities of substrate, and potentially lower costs.   
 
4.4  Conclusions 
A method has been presented for estimating the total turnover number (TTN), a 
dimensionless number which expresses the total moles of product yield per mole of 
biocatalyst during its operational lifetime.  The TTN for a biocatalyst at a given 
temperature of interest can be calculated as the quotient of the kcat,obs (apparent turnover 
number) and the kD,obs (first-order deactivation rate constant), both measured at the same 
temperature.  Many biocatalysts have been characterized in terms of specific activity and 
half-life, from which kcat,obs and kD,obs are easily derived.  This heuristic TTN estimation 
method assumes minimal prior knowledge of the enzyme’s deactivation pathway; it holds 
true for enzymes with any number of intermediate unfolding states provided that all 
inactive intermediates become permanently denatured via first-order kinetics.  This 
method has been shown to be effective in distinguishing the most suitable catalyst from a 
group of candidates with similar characteristics, though it should not be used as a method 
for determining an enzyme’s optimum operating temperature.  The TTN method may be 
extended to any biocatalyst which fits an apparent first-order denaturation profile and has 
an established activity assay method at the desired process temperature.  This method 
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allows the enzyme engineer to quickly, and with minimal experimental data, estimate the 
cost contribution of biocatalyst to the variable process costs and to select the most cost-
efficient candidate from a group of engineered catalysts with similar activity and 
stability. 
4.5  Publication Information 
The work presented in Chapter 4 of this dissertation was published in Chemical 
Engineering Science (Volume 65, Issue 6, pages 2118-2124) with my thesis advisor, 
Andreas S. Bommarius as co-author.  The date of initial on-line publication was 
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VALIDATION OF HEURISTIC AND ACCELERATED MODELING 
APPROACHES FOR ESTIMATING BIOCATALYST TOTAL 
TURNOVER NUMBER 
 
5.1  Introduction 
 Much research effort continues to be devoted to improving the stability of 
enzymes which have the potential to be used as biocatalysts in processes where high 
degrees of specificity and enantioselectivity are imperative.  By isolating or identifying 
enzymes with activity toward a desired substrate, and then incorporating structurally 
stabilizing mutations (either by random screening, analogy to known elements in similar 
thermophilic proteins, or a balance of the two), biocatalysts may be engineered to be 
specialized toward a given reaction. 
 Identifying potentially useful protein sequences is only part of the task; often, the 
search does not begin with one or two candidates, but rather dozens or even hundreds.  In 
the context of industrially viable biocatalysts, these candidates should have the ability to 
remain stable for weeks or months under the intended process conditions.  To 
independently measure the lifetime yield of a large number of potentially interesting 
enzymes becomes expensive in terms of substrate consumption, energy usage, and 
experimental time. The work presented herein compares two proposed alternatives to 
direct measurement of a biocatalyst’s lifetime yield, using TEM-1 β-lactamase as a test 
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case.  The total turnover number (TTN) is used in both cases as the preferred indicator of 
the productivity (which is then easily used to compare lifetime cost-effectiveness) of the 
enzyme. 
 The first alternative is a heuristic method which scales the observed activity 
(kcat,obs) to the observed deactivation rate constant (kD,obs) at a selected operating 
temperature.1 For purposes of consistency, the quantity kcat,obs should not be confused 
with the true kcat of the enzyme.2 Rather, it is the observed turnover frequency, with units 
of inverse time, of the enzyme-catalyzed reaction at the specified temperature.  
Importantly, kcat,obs takes into account the possibility that some of the enzyme has 
assumed a reversibly inactivated form (in rapid equilibrium with the active form at the 
time of measurement.3  Experiments which seek to measure the true kcat but fail to apply 
this inactivation “correction factor” are potentially erroneous.  Conveniently, the value of 
kcat,obs can be calculated from a specific activity measurement (U/mg) if the molecular 
weight of the enzyme is known (Equation 4-12).  The value of kD,obs is simply the 
observed rate constant when the enzyme’s residual activity vs. time curve is fitted to a 
first-order exponential decay rate law.  The majority of biocatalysts, even if multiple 
first-order deactivation pathways are present, will exhibit an overall first-order observed 
deactivation. Exceptions to this rule occur when second order effects such as protein 
aggregation become dominant. 
 The second alternative to direct measurement of lifetime yield is to conduct a 
single non-isothermal experiment in a continuous stirred-tank reactor (CSTR).4 This 
approach incorporates the principles of a temperature scanning reactor5 but applies a 
number of protein stability models (of varying complexity) to extract the intrinsic activity 
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and unfolding parameters of the enzyme, and identify the most relevant deactivation 
scheme.  The effects of the temperature scan rate on the mathematically-predicted 
enzyme parameters are critically examined, and guidelines for ensuring proper reactor 
configuration are developed. The results are compared to direct measurements of TTN at 
selected temperatures several degrees below the enzyme’s maximum operating 
temperature, which was not done in previous studies due to the extreme thermostability 
of the tested biocatalyst.4  
 To our knowledge, this is the only study to date which applies the accelerated 
modeling method to a soluble enzyme in a continuous system. A few examples of 
accelerated biocatalyst deactivation studies on immobilized enzymes can be found in the 
literature.6 Recently, a method was proposed for carrying out a similar analysis with a 
soluble esterase in 96-well plates through batch-mode experiments, and corroborated 
through direct measurement over the partial lifetime of the enzyme in fed-batch 
experiments.7  It should be noted that a batch-mode well-plate approach would become 
more difficult to use with highly active enzymes or enzymes with high KM values relative 
to the solubility of substrate, as substrate depletion in the wells can affect observed 
reaction rate. 
5.2  Experimental Methods 
5.2.1  Batch-mode Experiments 
 The corresponding values of kcat,obs and kD,obs were determined at several different 
temperatures through a series of initial activity and isothermal deactivation experiments, 
respectively, all performed in batch mode.  For the initial activity readings, 7.0 mL of the 
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substrate solution (20 mM penicillin G in 200 mM sodium phosphate buffer, pH 7.0) was 
placed into a sealed 15-mL centrifuge tube and pre-heated to the desired temperature for 
a minimum of 10 min.  A 50 μL sample containing 300 μg/mL of enzyme was added to 
the pre-heated tube of substrate solution, which was rapidly mixed by inversion (resulting 
in a final enzyme concentration of 66 nM).  The contents of the tube were immediately 
transferred to the sample cell of the polarimeter (Autopol II, Rudolph Research 
Analytical - Hackettstown, NJ), which was equipped with a temperature control jacket 
(set and preheated to the desired temperature). 
 The optical rotation of the mixture at 589 nm was recorded for a period of two 
minutes, over which the reaction kinetics remained pseudo-zero-order due to the substrate 
concentration (very well above KM) and the short timescale of the experiment.  The 
methods presented in Subsection 2.3.4.3 were used to convert the optical rotation data 
into reaction rate data.  At 57°C (the highest temperature used in the study) there was 
already slight non-linearity to the absorbance vs. time data (R2 = 0.96) but at 60°C the 
apparent deactivation was very fast and linearity was lost even through the first two 
minutes.  This observation, coupled with the fact that several seconds are required to mix 
and transfer the contents to the polarimeter - during which significant deactivation can 
occur at 60°C - none of the data above 57°C were used. 
   For the isothermal deactivation experiments, the enzyme was incubated in an 
external water bath at the desired temperature, and 50 μL samples were withdrawn at 
appropriate time intervals, with a minimum of six time points for each temperature tested.  
Each withdrawn sample was assayed for activity at the desired temperature using the 
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methods described in the preceding paragraphs.  For all temperatures used in this study, 
the residual activity vs. time plots obeyed a first-order decay equation, and so the 
apparent deactivation rate constant was determined at each temperature. 
5.2.2  EMR Temperature Ramps 
 The EMR described in Section 2.4 was programmed with linear heating profiles 
for each of the experiments at 1 K/h, 2 K/h, 4 K/h, 8 K/h, 12 K/h, and 16 K/h.  The feed 
solution used in all ramp experiments was 20 mM penicillin G in 200 mM sodium 
phosphate buffer, pH 7.0.  For each experiment, 2.6 μg of enzyme was injected into the 
reactor (for a total enzyme concentration of 8.2 nM) and the reactor was allowed to 
equilibrate for 1 h at 20°C as substrate solution was fed through the reactor at 1 mL/min.  
After the equilibration period, the linear heating profile was started and the optical 
rotation of the effluent stream was recorded at 30 s intervals using the attached 
polarimeter, along with the temperatures of the water bath and the reactor temperature 
jacket.  The polarimeter sample cell was maintained at 25°C by a dedicated water bath to 
eliminate any fluctuations in ambient temperature.   Due to apparent heat loss through the 
reactor vessel walls, the temperature in the reactor jacket deviated slightly from that of 
the programmed temperature bath at the extremes, so the reactor jacket temperature was 
used in all calculations.   
 The raw optical conversion data was processed by first manually removing outlier 
data points which resulted from transient air bubbles in the polarimeter cell channel.  
Secondly, when necessary for the longer-duration ramps, the data was truncated shortly 
after the enzyme had decayed to zero residual activity, as some of the models had 
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difficulty fitting a long “tail” where the instrument noise eclipses the activity reading.  
Next, the data was smoothed in MATLAB® with the Curve Fitting ToolboxTM, using a 
Robust Loess method with span = 85.  Lastly, the optical rotation data was converted to 
reaction rate data using Equations 2-10 and 2-11. 
5.2.3  Direct Isothermal Measurement 
 Measurements of the total product output over the enzyme lifetime were 
conducted by operating the EMR isothermally until the apparent reaction rate was too 
low to be measured.  The total yield was measured at five different temperatures:  42°C, 
45°C, 48°C, 51°C, and 54°C.  The experimental duration and efficiency of substrate use 
would have been unreasonable at lower temperatures, and the timescales of enzyme 
deactivation and reactor mixing would have been too similar at higher temperatures (see 
Section 5.2.4).  In each case, a feed flow rate of 1 mL/min was used and 2.6 μg of 
enzyme were injected into the reactor, for a final catalyst concentration of 8.2 nM.  The 
reactor was preheated for a minimum of 1 h prior to the addition of enzyme, after which 
the measurement of effluent optical rotation began immediately.  Once the conversion 
had decreased to a value nearly indistinguishable from instrument noise (generally 3-5% 
residual activity), the reactions were stopped. 
 Outlier data points due to transient air bubbles in the polarimeter cell were 
manually removed, and the optical rotation data was converted to reaction rate data 
according to Equations 2-10 and 2-11. The area under the reaction vs. time curve for the 
entire experiment was found using the “Area below curves” toolbox command in 
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SigmaPlot® (Version 8.0), giving the total yield per unit volume of the reactor.  This area 
was then divided by the enzyme concentration in the reactor to give the TTN. 
5.2.4  Timescale Considerations 
 In both the temperature ramp and isothermal experiments involving the EMR, 
proper reactor design principles must be followed to ensure that the reaction rate behavior 
accurately reflects the phenomena under study - enzyme deactivation - rather than mixing 
or other transport effects.  In essence, the characteristic time for deactivation should 
always be the longest (rate-limiting) timescale in an experiment. Similarly, in the ramp 
experiments, the rate of increase in reactor temperature should not be so fast that the 
contents of the reactor do not have time to equilibrate to the rapidly changing conditions.  
The relevant timescales for this experiment (which were defined in Section 2.4.3), using 
the physical parameters of the system as well as activity and deactivation data from the 
batch experiments, are shown in Table 5.1. 
5.2.5  Modeling Analysis 
 For each ramp rate, five different deactivation models were used to describe the 
reaction rate with respect to temperature and time.  These five models are shown in 
Figure 5.1. In the case of all five models, the expression for the modeled reaction rate at 
any point during the course of an experiment is given by Equation 5-1. 
),]()[,(),( tTNtTktTr cat=  [5-1] 
The functional form of kcat is known (Equation 3.1) and thus its value is easily calculated.  
However, the quantity [N] depends on the history within the reactor (i.e. the cumulative 
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loss of protein to the denatured state as the non-isothermal experiment progresses).  Since 
temperature and time are conveniently coupled in a linear relationship, as in Equation 5-2 
where m is equal to the experimentally measured slope of the heating profile, [N] can be 
reduced to a function of time only. 
mtTtT += 0)( [5-2] 
Even with the above simplification, however, an analytical solution for [N](t) is 
exceedingly unlikely.  Indeed, even with the simplest model (model 1), the expression for 
[N] as a function of elapsed time tx is given by Equation 5-3. 
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Not only are none of the three quantities inside the integral constant with respect to time 
in these non-isothermal experiments, but the function [N](t) appears both inside and 
outside of the integral; its value depends on its own integral in accordance with the notion 
that its value depends on the reaction history.  It is therefore easier to derive a first-order 
differential equation for [N] based on the species balance, which for model 1 takes the 







































In this manner, the value of [N](t) can be numerically evaluated by means of a simple 
Euler method: using the starting value of [N], approximating Δ[N]/Δt over each 
sufficiently small 30 s time step via Equation 5-4, and using the result as the model value 
of [N] at the end point (which is fed as the initial value to the next time step).  The 
modeled reaction rate can then be expressed by Equation 5-1 - but since the experimental 
data measures the rate and does not directly measure [N], incremental changes in r(t) 












The final expressions for the incremental change in reaction rate with respect to time for 
each of the five models, as well as the associated initial value [N]t=0 used in each 
numerical approximation, are given in Table 5.2.  Note that the derivatives of equilibrium 
expressions and rate constants appear in each final derivative, but the forms of these 



























































Table 5.2  Expressions for differential change in reaction rate. 
Model 
dt
































































































































































































































































 An Excel routine was written which uses the built in Solver function, based on the 
Generalized Reduced Gradient (GRG2) nonlinear optimization code,8 to minimize the 
sum of residuals squared between the experimental data points and the rate data predicted 
at each time/temperature point by the respective model. The Excel which was used to 
create the solver objective function is shown in Appendix B. The following algorithm 
options were selected:  tangent estimates, central derivatives, Newton search.  The solver 
routine was set to terminate when the fitted parameters converged to values which varied 
less than 0.01 over five consecutive iterations, or when 200 iterations had been attempted, 
whichever occurred first.  Initial guesses for every fitting parameter were supplied to the 
model, and the best results were achieved when two of the parameters in particular - 
ΔGcat and the Τm leading to state U - matched well to the experimental data.  These two 
parameters are tied closely to the shape of the reaction profile, as the ΔGcat should give 
an initial rate which matches the observed rate at the start of the ramp, and the final Τm 
sets the point at which the sudden drop in rate occurs.  Poor initial estimates of these 
parameters had tremendous effect on the model’s degree of fit.  Fitting was performed at 
each of the six scan rates, for each of the five models. 
5.3  Results and Discussion 
5.3.1  Heuristic TTN Estimation 
 The values of kcat,obs and kd,obs for each of the seven tested temperatures are shown 
in Table 5.3. The calculated enzyme half-life from kD,obs, assuming a first-order 
deactivation rate law, is also shown for each temperature.  Interestingly, the observed 
initial activity remains relatively constant as the temperature increases from 37°C to 45°C 
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and clearly does not follow an exponentially increasing Arrhenius-type behavior.  This 
indicates that there is a likely effect of thermodynamic unfolding equilibrium competing 
with the expected increase in reaction rate.  The TTN at each temperature was calculated 
according to the heuristic method of Equation 4-11, and it was observed that there was 
approximately a three order of magnitude decrease in TTN as the temperature increased 
from 42°C to 54°C. Error bars were not constructed for TTN estimates, as the low 
temperature runs were only single experiments due to the long duration, but the observed 
trend in TTN vs. temperature was nonetheless very clear. 
Table 5.3  TTN estimation from 37-57°C using the heuristic approach. 
Temperature 
(K) 
kcat,obs        
(s-1) 
kD,obs           
(s-1) 
half-life       
(h) 
TTN       
(dimensionless) 
37 1552 2.28e-06 84.3 6.81e+08 
42 1560 4.09e-06 47.1 3.81e+08 
45 1476 8.26e-06 23.3 1.79e+08 
48 1417 3.84e-05 5.01 3.69e+07 
51 1250 1.22e-04 1.58 1.02e+07 
54 775 3.30e-04 0.58 2.35e+06 
57 440 1.16e-03 0.17 3.79e+05 
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5.3.2  Accelerated TTN Estimation 
 All of the non-isothermal temperature ramp modeling results are contained in 
Appendix C, with representative examples shown in the body of this section for purposes 
of discussion.  The effects of the temperature ramp rate and choice of stability model on 
the goodness of fit to experimental data are shown in Table 5.4.  The values in the table 
are the average percentage by which the predicted model values of the reaction rate differ 
from the corresponding experimental values.  The fit became slightly worse for all five 
models as the ramp rate increased to 12 K/h and above.  This is due to the fact that at the 
high temperature portion of these ramps, the reactor effluent still contains product which 
was produced by enzyme that was still active one residence time before the measurement 
was taken. 
 As such, the guideline which was established in Table 5.1 - that the time needed 
for reactor temperature to increase by 1 K should not be less than one full residence time 
of the reactor - is manifested in the data.  Figure 5.2 illustrates the difference (for model 3 
only) between reaction data collected at 2 K/h and 16 K/h, and the corresponding fits to 
model 3.  The deviations occur at the beginning and end of the ramp as expected when 
there is a delay between CSTR flow and observed deactivation, and notably the enzyme’s 
apparent activity for the 16 K/h ramp is nowhere near zero at the end of the experiment 
when the reactor temperature is 60°C.  Batch experiments confirmed that the enzyme 
should lose all activity on the order of one minute at 60°C. 
 Comparing the three- and four-state models at the ramp rate in the middle of the 
acceptable range (the 4 K/h ramp), it was found that neither of the three-state models 
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were able to match the experimental data with an accuracy better than 10%.  All three of 
the four-state models 4 and 5, though they contain more parameters, consistently result in 
fits which are almost indistinguishable from those of model 3 (see Appendix C).  The 
three-state models, on the other hand, are unable to match the rather shallow rate increase 
(i.e. non-Arrhenius behavior) observed in the low-temperature segment of the 
experiment.  Manually lowering the Tm and the ΔH parameters for these models the four-
state models were able to converge equally well such that the fitting error was only about 
1%. Models 1 and 3 (at the 4 K/h ramp rate) are used as representative examples in the 
comparison shown in Figure 5.3. 
 
Table 5.4  Average percentage error of fit for five models, all ramp rates. 
Model 1 K/hr 2 K/hr 4 K/hr 8 K/hr 12 K/hr 16 K/hr 
1 13.4 13.7 14.8 12.5 10.3 5.6 
2 13.3 13.6 14.9 12.7 10.5 5.7 
3 1.1 0.7 0.8 1.6 3.9 3.3 
4 1.1 0.7 0.9 1.4 1.9 3.5 




Figure 5.2  Comparison of slow and fast temperature ramp rates, model 3. 
 
Figure 5.3  Comparison of selected three- and four-state models, 4 K/h ramp.  
 The four-state models 4 and 5, though they contain more parameters, consistently 
result in fits which are almost indistinguishable from those of model 3 (see Appendix C).  
The three-state models, on the other hand, are unable to match the rather shallow rate 
increase (i.e. non-Arrhenius behavior) observed in the low-temperature segment of the 
experiment.  Manually lowering the Tm and the ΔH parameters for these models 
(essentially modeling “easier” unfolding) improves the fit of the model at low 
temperatures but then far underestimates the activity at higher temperatures. Similarly, 
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setting these parameters higher can bring the model closer to showing sudden 
deactivation at the end of the ramp, but then indicates almost no deactivation should 
happen until this transition is reached.  These are the consequences of trying to use only 
one thermodynamic transition in the model when in reality there may be two:  the gradual 
destabilization of the active site which keeps the activity profile flat at low temperatures, 
and the complete loss of secondary structure once the melting temperature is reached.  
The effects of the aforementioned manual changes to the fitting parameters are shown in 
Figure 5.4.  This exercise was conducted with the 4 K/h ramp data, model 1. 
 The fitting parameters achieved by all five models at all scan rates are shown in 
Table 5.5.  Worth noting is that models 1 and 2 resulted in a low level of consistency in 
the parameters ΔH1 and Tm,1, at times even giving values which would indicate the 
enzyme is 50% thermodynamically unfolded at 234 K, a clearly incorrect result.  The 
four-state models were rather consistent in predicting parameters at ramp rates 8 K/h and 
slower.  There was a significant trend in Tm,1 - slightly decreasing as the ramp rate 
increased - which was accompanied by a corresponding decrease in the ΔGcat.  The 
correlation between these two parameters is expected; to match the observed reaction rate 
at the beginning of the ramp, a decrease in the energy barrier for the enzyme-catalyzed 
reaction can be offset by a decrease in the temperature at which thermodynamically-
controlled inactivation begins.  The most likely explanation for the variation between 
models is that the different scan rate experiments involve slightly different levels of 
cumulative denatured protein as the experiment progresses and therefore a slightly 
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Figure 5.4  Relative inflexibility of model 1 in capturing two deactivation regimes. 
different overall rate trajectory in the early part of the ramp before the effects of the 
second transition dominate.  It should be noted that model 3 showed the least variation, 
predicting the Tm,1 within 6°C (or, ignoring the 1 K/h ramp, 2°C) at ramp rates 8 K/h and 
slower. 
 The agreement of parameter values between models 3, 4, and 5 is quite good, and 
it was apparent that the addition of denaturation paths from states other than U had only 
slight effect on the estimated parameter values - though these differences can become 
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Table 5.5  Fitting parameters obtained from five models, all ramp rates. 
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magnified when estimating the TTN as seen later in this section.  At least in the case of 
ΔGD,3 in model 5, the value did not significantly change from its initial guess (120 
kJ/mol) and the same lack of sensitivity was observed when guesses between 100-160 
kJ/mol were used.  This is evidence that the effects of a direct path from N to D are 
unnecessary in model 5; including ΔGD,3 in the model amounts to overparameterization.  
The parameter ΔGD,2, from M to D, did vary somewhat from its initial guess (113 kJ/mol 
in all cases but the 1 K/h ramp which was 120 kJ/mol) but only by about 0.1% indicating 
the effects of this pathway are also eclisped by more dominant mechanisms.  Once again, 
model 3 was demonstrated to be the model with the fewest parameters which can still 
produce the same degree of fit as models 4 and 5. 
 Table 5.6 shows a comparison of TTN predictions from all five models at various 
temperatures, along with calculated values of the thermodynamic and kinetic rate 
constants, using the data from one of the intermediate ramp speeds (4 K/h).  It can be 
immediately seen that models 1 and 2 predict less than one order of magnitude change in 
TTN as the temperature is varied from 37°C to 54°C.  This is an unrealistic result and is 
in sharp contrast to both the direct TTN measurements (presented in the next section) and 
the short-term batch observations.  The TTN values predicted by models 3, 4, and 5 agree 
rather well at higher temperatures, but start to show significant differences at lower 
temperatures (factor of 40 difference at 37°C, factor of 4 difference at 42°C, factor of 2 
or better at all higher temperatures).  Model 3 predicts a 73000-fold higher TTN at 37°C 
than at 54°C, while models 4 and 5 both only predict about an 1800-fold increase.  As the 
kcat,obs for all three models agree very closely at low temperatures, the source of this 
difference is the much smaller kD,obs predicted by model 3 as compared to models 4 and 
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5.  The agreement between all three models and the batch-mode heuristic data worsens as 
the temperature decreases, again due to differences in kD,obs. 
 To revisit the effects of temperature ramp rate, model 3 TTN predictions were 
examined for all six experimental ramps at six temperatures (Table 5.7).  The ramps 
between 1 K/h and 8 K/h again produced similar results; a factor of 3 or better at all 
temperatures with best agreement at high temperatures.  The 12 K/h ramp widened the 
error margin to a factor of 7, and the 16 K/h ramp to a factor of 15. 
5.3.3  Comparison to Direct TTN Measurement 
 The actual product yield over the course of the enzyme lifetime was examined at 
five different tempeartures; the results are shown in Table 5.8 and are compared to the 
heuristic and accelerated methods.  A direct isothermal experiment was attempted at 
37°C but was terminated due to instrument failure after approximately 10 days, well 
before the residual activity of the enzyme was gone. This run was not pursued further due 
to the very long duration and inefficient use of substrate.  Nonetheless, the directly 
measured TTN at 42°C shows that there is already a factor of 2200x change in TTN 
between 42°C and 54°C.  This result indicates not only that the heuristic method begins 
to underestimate TTN as the operating temperature becomes more remote from the Tm of 
the enzyme, but also that the change in TTN over this range is better captured by model 3 
than by models 4 and 5 (the data for model 3 is shown in Table 5.8). 
 In summary, both the heuristic batch method and the accelerated temperature 
ramp method, when used in conjuction with the appropriate model (model 3, at any 
intermediate scan rate), can be used to predict the actual TTN within a factor of 3 at any 
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Table 5.6  TTN prediction from 37-54°C for five models, 4 K/h ramp rate. 
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Table 5.7  TTN prediction from 37-54°C for all ramp rates, model 3. 
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temperature between 45-54°C (i.e., the uppermost 10°C of this enzyme’s operable range).  
At lower temperatures, the continuous non-isothermal modeling approach appears to be 
more favorable than the heuristic method both in terms of TTN prediction accuracy and 
the length of the necessary experiments. Therefore, the heuristic method is an attractive 
option when the desired operating temperature is near the anticipated upper limit of the 
enzyme’s thermal stability range since it involves relatively short experiments which 
require only common equipment, low amounts of substrate, and no reactor design 
concerns.  When the enzyme is to be operated in the regime where it is expected to be 
stable for weeks or months, or when the required operating temperature is unspecified, 
the accelerated modeling approach should be used in every case.  
Table 5.8  Comparison of heuristic and modeling TTN estimations to directly measured 
TTN values at selected temperatures. 
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5.4  Conclusions 
 We have presented two approaches for circumventing the need to directly 
measure the total product yield of a biocatalyst over the entire duration of its lifetime.  
Both methods resulted in TTN estimations that were well within one order of magnitude 
of the results obtained through the direct measurements (which, especially at low 
temperatures, are exceedingly slow and potentially troublesome in terms of limited 
equipment reliability and high substrate consumption).  This level of accuracy renders 
these methods useful for quick estimates of biocatalyst stability, including estimations of 
their costs, especially with regard to initial screening of libraries of enzymes which are 
potential candidates to be used as the biocatalyst in an industrial process. 
 The relative strengths of each of the two presented methods are apparent.  The 
heuristic approach of collecting kcat,obs and kD,obs values is favored when the process 
temperature is approximately known (so that repeated experiments at multiple 
temperatures are not required) and when that temperature is near the anticipated upper 
limit of the enzyme’s stability (so that the duration of the deactivation experiments are 
reasonably short).  Even if the intended process temperature is low, the protein engineer 
can quickly obtain a TTN estimate for the enzyme if its specific activity and half-life data 
have already been obtained or are available in the literature. 
 The non-isothermal temperature ramp modeling approach is most useful when the 
enzyme is to be used at a process temperature well under its anticipated stability limit, or 
when the process temperature is unknown.  By evaluating the intrinsic thermodynamic 
and kinetic parameters of the biocatalyst through modeling, one can then predict the TTN 
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at any desired temperature.  An additional benefit of the modeling approach is that if the 
exact deactivation mechanism of an enzyme is not known, multiple stability models can 
be examined, as shown in this work, and the model which is able to accurately fit the data 
with the fewest parameters can be selected. 
5.5  Publication Information 
 This work presented in Chapter 5 of this dissertation has been submitted as a 
manuscript to Biotechnology and Bioengineering with my thesis advisor, Andreas S. 
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CONCLUSION AND RECOMMENDATIONS 
 
 Highly stable biocatalysts, though they are ultimately very good news in the 
context of large-scale bioprocesses, can present certain challenges for the protein 
engineers who develop them. The very same quality that renders an enzyme desirable to 
use in a long-term process makes it expensive, time-consuming, and potentially difficult 
to directly measure and document the enzyme’s lifetime productivity.  We have presented 
two distinct methods for obtaining accurate estimates of a biocatalyst’s total turnover 
number, both of which can potentially circumvent many hundreds of hours of stability 
characterization as compared to direct measurement. 
 The comparison of the isothermal batch-mode experimental techniques (fitted to 
the Equilibrium Model) to the non-isothermal continuous-mode experiments (fitted to the 
molten globule model) in Chapter 3 elucidated the importance of timescale in enzyme 
deactivation experiments.  Effects which may not be easily observed during assays a few 
minutes in duration could manifest themselves in a much more significant way in an 
experiment lasting for hours or days.  Despite a few differences in the numerical results, 
both methods showed conclusively that TEM-1 β-lactamase is an enzyme which does not 
obey the classical Lumry-Eyring model and provides contrary evidence to the widespread 
belief that enzymes should operate at temperatures just below their melting point for peak 
performance.  In general, the collaboration with the Daniel lab has made us keenly aware 
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of the concept of temperature optima and that deactivation and unfolding are clearly not 
synonymous in all cases. 
 The development of the heuristic method in Chapter 4 begins with the most 
generalizable model of enzyme deactivation and mathematically reduces it to a very 
simple expression, with two terms that correspond to easily measurable experimental 
values, for estimating a biocatalyst total turnover number.  We have demonstrated the 
applicability of this method in selecting the best candidate from a small assortment of 
similarly thermostable enzymes, and have verified the method through comparison to 
directly measured TTN values of the mesophilic TEM-1 β-lactamase.  The heuristic 
method is still somewhat limited, as we demonstrate, when a catalyst is being tested at 
temperatures far below its upper stability limit.  To obtain an accurate value of kD,obs 
through simple residual activity measurements, one should expose a biocatalyst to the 
denaturing condition for at least three half-lives to ensure a good fit to an exponential 
decay rate law. For highly stable catalysts, the required experiments become prohibitively 
long and the direct measurement option starts to appear more competitive. 
 Suggestions for future work related to the heuristic model are i.) perform the 
heuristic estimation vs. direct TTN measurement approach on a variety of different 
enzymes which exhibit overall first-order kinetic deactivation, to assess its 
generalizability and ii.) determine the magnitude of error that arises when non-first-order 
mechanisms such as aggregation or subunit interactions are present and, if necessary, 
develop analogous heuristic expressions which can be used when these mechanisms are 
confirmed or expected.  While these multiple-mechanism heuristics will not be reducible 
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to such an elegant form as Equation 4-11 and will require additional enzyme-specific 
information about the non-thermal deactivation routes, they could nonetheless be useful. 
 The work presented in Chapter 5 is the capstone piece to our study of both 
accelerated non-isothermal methods and heuristic estimations from kcat,obs and kD,obs.  To 
our knowledge, it is the only study to date which subjects a soluble enzyme (not 
immobilized, as this can alter or obscure enzyme stability parameters) to an accelerated, 
continuous, non-isothermal deactivation experiment and then directly compares TTN 
predictions to the results of complete isothermal deactivation studies also performed in 
continuous mode. The examination of several stability models in conjunction with the 
temperature ramp studies, ranging from the simple three-state Lumry-Eyring model to the 
highly generalized four-state model with irreversible denaturation pathways available 
from each of the first three states, demonstrates how an assessment of the goodness of 
model fit can be used to select the model which will best predict the true TTN. 
 Aside from the logical recommendation that the continuous EMR temperature 
ramp method be tested on other soluble enzymes, especially ones which we suspect may 
have a temperature optimum far below their melting temperature (as indicated by an 
attenuated rise in specific activity through the temperature range preceding Tm), we 
would like to further investigate the mathematical model fitting techniques. The Euler-
type numerical integration used in Chapter 5 should have a high degree of accuracy due 
to the small time step made possible by our novel in-line polarimetric assay. However, 
the experimental data to which the model must be fitted (here, reaction rate) is in reality 
the solution to a complex function involving the unobservable state [N]. Theoretically, 
the concentration of native enzyme remaining in the reactor could be directly measured 
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by absorbance or fluorescence, but this would require an extremely complicated 
experimental setup.  One potential avenue for improving the models is to use nonlinear 
state estimation,1,2 which has demonstrated utility in systems where the observable 
instrument output is governed by one or more nonlinear differential equations involving a 
non-observed system state that depends on system inputs (in our case, reactor 
temperature) and time.  Again, while our current numerical fits are already very good 
(less than 1% error on the four-state models) it may be interesting to use the nonlinear 
estimation approach to independently follow the changes in activity and cumulative 
denaturation through the course of a temperature ramp. 
 The two rapid TTN estimation methods described in our work were shown to 
eliminate the need for the third method (direct measurement over entire enzyme lifetime) 
which should only be used in the very late stages of biocatalyst screening and selection to 
confirm the accuracy of the heuristic or modeling methods.  The heuristic method is 
particularly useful when published half-life and specific activity data are already known, 
or when the TTN estimation only needs to be carried out at one temperature which is in 
the vicinity of the enzyme’s upper stability limit.  The modeling approach takes the 
results from a single experiment and generates an estimate for TTN for any desired 
temperature, avoiding the need for an array of isothermal deactivation experiments, and 
can even be used to gain information about the true deactivation mechanism that takes 
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RIGOROUS MATHEMATICAL DERIVATION OF THE 
HEURISTIC TOTAL TURNOVER ESTIMATION METHOD 
 
 Demonstrated herein is the complete derivation for [N](t), the concentration of 
native, active enzyme remaining at time t during an isothermal process, based on the 
multiple pathway deactivation model in Figure 4.5.  Firstly, a mass balance is performed 
on all enzyme species that occupy any of the different conformations including a number 
n of stable intermediates.  Assuming a closed system with constant volume, the mass 
balance takes the form of Equation A1, where [E]0 is the initial concentration of enzyme 
in the system.  Next, the definitions of the equilibrium constants are applied to the mass 
balance.  The concentration of each of the intermediate states may then be written in 
terms of [N].  For example, since K1 = [I1]/[N] such that [I1] = K1[N] and furthermore K2 
= [I2]/[I1] such that [I2] = K2[I1] = K2K1[N], the mass balance can be rewritten as 
Equation A2 and then factored as in Equation A3.  The resulting expression is then 
condensed using summation notation according to Equation A4. 
 







































































 Each of the transition equilibria is treated as a van’t Hoff relationship in which the 
equilibrium constant Kn depends on temperature as well as the parameters Tn (the 
temperature at which [In]/[In-1] equals unity) and ΔHn (the enthalpy change associated 
with the transition from In-1 to In).  The van’t Hoff relationship is shown in Equation A5, 
where R is the gas constant.  It is hereby assumed that at the initial time t = 0, the 
equilibria between the native and intermediate states are rapidly (essentially 
instantaneously) established and that none of the enzyme has yet decayed to a denatured 






































 To establish the time dependence of [N], Equation A4 is differentiated with 
respect to time as shown in Equation A7.  Since all equilibrium constants are functions of 
temperature according to the van’t Hoff relationship and should not vary with time in an 
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 The rate of accumulation of denatured enzyme is then assumed to equal the sum 
of the contributions from all native and intermediate states (which is valid if all pathways 
to D in Figure 4.5 obey first-order kinetics).  Each of the first-order decay processes is 
assumed to have a rate constant kD,n which may be modeled by thermodynamic transition 
state theory as in Equation A8.  Here, kB = Boltzmann constant,    h = Planck’s constant, 
R = gas constant, and ΔGn is the Gibbs free enthalpy change upon In transitioning to a 
denatured state.  These deactivation rate constants, which are functions of temperature, 
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 The total rate of accumulation is shown in Equation A9 which can be put in terms 
of [N] by again applying the definitions of the equilibrium constants, leading to Equation 
A10.  Summation notation is then used to condense the expression according to Equation 
A12. 
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 Equations A7 and A12 are combined to form Equation A13, and rearrangement 
yields the first-order differential equation in Equation A14.  Since the coefficient is a 
constant under isothermal conditions, the system may be solved via separation of 
variables using the initial condition already set forth in Equation A6.  The particular 


























































































































































SAMPLE CALCULATION: MICROSOFT EXCEL CODE 
 
 Shown below is the spreadsheet programming for Model 5 which uses the 
differential approximation listed in Table 5.2.  The simpler models, 1-4, rely on the same 
method but blocks are deleted when the parameter does not exist within the particular 
model.  The cells which contain adjustable parameter values are in bold and the objective 
cell of the built-in Generalized Reduced Gradient (GRG2) solver routine is underlined. 
 
Fixed Value Cells 
Z3 = 1.38065E-23   Boltzmann constant 
Z4 = 6.62607E-34   Planck constant 
Z5 = 8.31447           Gas constant 





Z15 = Gcat, initial guess 
Z16 = H1, initial guess 
Z17 = Tm1, initial guess 
Z18 = H2, initial guess 
Z19 = Tm2, initial guess 
Z20 = Gd1, initial guess 
Z21 = Gd2, initial guess 
Z22 = Gd3, initial guess 
 
Objective Cell 




A:  <time data, seconds> 
B:  <temp data, Kelvin> 
C:  <rate data, M-1 s-1> 
D:  =($Z$3/$Z$4)*B1*EXP(-$Z$15/($Z$5*B1))       kcat value 
E:  =($Z$3/$Z$4)*((B2-B1)/(A2-A1))*EXP($Z$15/($Z$5*B1)) 
 *(1+($Z$15/($Z$5*B1)))       dkcat/dt value 
F:  =EXP(($Z$16/$Z$5)*((1/$Z$17)-(1/B1)))      K1 value 
G:  =((B2-B1)/(A2-A1))*($Z$16/$Z$5)*(1/(B1^2))*EXP(($Z$16/$Z$5) 
 *((1/$Z$17)-(1/B1)))      dK1/dt value 
H:  =EXP(($Z$18/$Z$5)*((1/$Z$19)-(1/B1)))      K2 value 
I:  =((B2-B1)/(A2-A1))*($Z$18/$Z$5)*(1/(B1^2))*EXP(($Z$18/$Z$5) 
 *((1/$Z$19)-(1/B1)))      dK2/dt value 
J:  =($Z$3/$Z$4)*B1*EXP(-$Z$20/($Z$5*B1))      kd1 value 
K:  =($Z$3/$Z$4)*B1*EXP(-$Z$21/($Z$5*B1))      kd2 value 
L:  =($Z$3/$Z$4)*B1*EXP(-$Z$22/($Z$5*B1))      kd3 value 
M (first row):  =$Z$10/(1+F1+(F1*H1))      initial condition N t=0 
M (all other rows):  =Q(n-1) where n = current row number, result for N after 
 previous time step 
N:  =M1*D1      rate before 
O:  =M1*(E1-D1*(G1+F1*I1+H1*G1+F1*H1*J1+K1*F1+L1)/(1+F1+F1*H1)) 
 differential change 
P:  =N1+(A2-A1)*O1      rate after 
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Q:  =P1/D2      native enzyme after, feed to cell M of next row 
R:  =Q1*F1      molten enzyme after 
S:   =Q1*F1*H1      unfolded enzyme after 
T:  =$Z$10-Q1-R1-S1      denatured enzyme after, from species balance 





































TEMPERATURE RAMP MODELING RESULTS: FIVE MODELS, 
ALL RAMP RATES 
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